LU92422I2 - Taxol - Google Patents

Taxol Download PDF

Info

Publication number: LU92422I2
Authority: LU; Luxembourg
Prior art keywords: taxol; factor; angiogenic; urethral; tracheal
Prior art date: 1993-07-19

Application number

LU92422C

Other languages

English (en)

Original Assignee

Angiotech Pharm Inc

Univ British Columbia

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-07-19

Filing date

2014-04-03

Publication date

2015-01-20

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22245764&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LU92422(I2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2014-04-03 Application filed by Angiotech Pharm Inc, Univ British Columbia filed Critical Angiotech Pharm Inc

2015-01-20 Publication of LU92422I2 publication Critical patent/LU92422I2/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/12—Ketones
- A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/55—Protease inhibitors
- A61K38/57—Protease inhibitors from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
- A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1658—Proteins, e.g. albumin, gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5005—Wall or coating material
- A61K9/5021—Organic macromolecular compounds
- A61K9/5031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
- A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/08—Materials for coatings
- A61L31/10—Macromolecular materials
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/145—Hydrogels or hydrocolloids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L31/16—Biologically active materials, e.g. therapeutic substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L23/00—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers
- C08L23/02—Compositions of homopolymers or copolymers of unsaturated aliphatic hydrocarbons having only one carbon-to-carbon double bond; Compositions of derivatives of such polymers not modified by chemical after-treatment
- C08L23/04—Homopolymers or copolymers of ethene
- C08L23/08—Copolymers of ethene
- C08L23/0846—Copolymers of ethene with unsaturated hydrocarbons containing atoms other than carbon or hydrogen
- C08L23/0853—Ethene vinyl acetate copolymers
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L67/00—Compositions of polyesters obtained by reactions forming a carboxylic ester link in the main chain; Compositions of derivatives of such polymers
- C08L67/04—Polyesters derived from hydroxycarboxylic acids, e.g. lactones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/606—Coatings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/62—Encapsulated active agents, e.g. emulsified droplets
- A61L2300/622—Microcapsules
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/36—Materials or treatment for tissue regeneration for embolization or occlusion, e.g. vaso-occlusive compositions or devices
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2203/00—Applications
- C08L2203/02—Applications for biomedical use
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L2312/00—Crosslinking
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L29/00—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers of esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers
- C08L29/02—Homopolymers or copolymers of unsaturated alcohols
- C08L29/04—Polyvinyl alcohol; Partially hydrolysed homopolymers or copolymers of esters of unsaturated alcohols with saturated carboxylic acids
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/70—Nanostructure
- Y10S977/773—Nanoparticle, i.e. structure having three dimensions of 100 nm or less
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S977/00—Nanotechnology
- Y10S977/902—Specified use of nanostructure
- Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
- Y10S977/915—Therapeutic or pharmaceutical composition

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Heart & Thoracic Surgery (AREA)
Vascular Medicine (AREA)
Inorganic Chemistry (AREA)
Surgery (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Ophthalmology & Optometry (AREA)
Gastroenterology & Hepatology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Polymers & Plastics (AREA)
Optics & Photonics (AREA)
Nanotechnology (AREA)
Immunology (AREA)
Cardiology (AREA)
Genetics & Genomics (AREA)
Dermatology (AREA)
Diabetes (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Hematology (AREA)
Dispersion Chemistry (AREA)
Urology & Nephrology (AREA)
Zoology (AREA)

LU92422C 1993-07-19 2014-04-03 Taxol LU92422I2 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US9453693A	1993-07-19	1993-07-19

Publications (1)

Publication Number	Publication Date
LU92422I2 true LU92422I2 (en)	2015-01-20

Family

ID=22245764

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
LU92423C LU92423I2 (en)	1993-07-19	2014-04-03	Taxol-eluting stent
LU92422C LU92422I2 (en)	1993-07-19	2014-04-03	Taxol

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
LU92423C LU92423I2 (en)	1993-07-19	2014-04-03	Taxol-eluting stent

Country Status (19)

Country	Link
US (23)	US6506411B2 (xx)
EP (13)	EP1159975B1 (xx)
JP (4)	JP3423317B2 (xx)
KR (5)	KR100389223B1 (xx)
CN (7)	CN1138505C (xx)
AT (10)	ATE277649T1 (xx)
AU (1)	AU693797B2 (xx)
CA (4)	CA2468375A1 (xx)
DE (10)	DE69435002T2 (xx)
DK (5)	DK1155689T3 (xx)
ES (5)	ES2290074T3 (xx)
GR (1)	GR3024833T3 (xx)
HK (1)	HK1042054B (xx)
LU (2)	LU92423I2 (xx)
NO (2)	NO324275B1 (xx)
NZ (5)	NZ511762A (xx)
PT (4)	PT1155689E (xx)
RU (3)	RU2180844C2 (xx)
WO (1)	WO1995003036A1 (xx)

Families Citing this family (452)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5853746A (en) *	1991-01-31	1998-12-29	Robert Francis Shaw	Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
US6515009B1 (en) *	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en)	1993-01-28	1999-11-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
KR100389223B1 (ko) *	1993-07-19	2003-10-08	안지오제네시스 테크놀로지스, 인코포레이티드	생체내통로관강을개방유지하기위한스텐트및이의제조방법
US20030203976A1 (en) *	1993-07-19	2003-10-30	William L. Hunter	Anti-angiogenic compositions and methods of use
US5886026A (en) *	1993-07-19	1999-03-23	Angiotech Pharmaceuticals Inc.	Anti-angiogenic compositions and methods of use
ATE255412T1 (de) *	1993-07-29	2003-12-15	Us Gov Health & Human Serv	Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators
US6028118A (en) *	1996-08-08	2000-02-22	Les Laboratoires Aeterna Inc.	Methods of using extracts of shark cartilage
US6380366B1 (en)	1994-04-28	2002-04-30	Les Laboratoires Aeterna Inc.	Shark cartilage extract:process of making, methods of using and compositions thereof
US6025334A (en) *	1994-04-28	2000-02-15	Les Laboratoires Aeterna Inc.	Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US5618925A (en) *	1994-04-28	1997-04-08	Les Laboratories Aeterna Inc.	Extracts of shark cartilage having an anti-angiogenic activity and an effect on tumor regression; process of making thereof
US6558798B2 (en)	1995-02-22	2003-05-06	Scimed Life Systems, Inc.	Hydrophilic coating and substrates coated therewith having enhanced durability and lubricity
US5605696A (en) *	1995-03-30	1997-02-25	Advanced Cardiovascular Systems, Inc.	Drug loaded polymeric material and method of manufacture
US7846202B2 (en) *	1995-06-07	2010-12-07	Cook Incorporated	Coated implantable medical device
US7896914B2 (en) *	1995-06-07	2011-03-01	Cook Incorporated	Coated implantable medical device
US7550005B2 (en)	1995-06-07	2009-06-23	Cook Incorporated	Coated implantable medical device
US7611533B2 (en)	1995-06-07	2009-11-03	Cook Incorporated	Coated implantable medical device
US20070203520A1 (en) *	1995-06-07	2007-08-30	Dennis Griffin	Endovascular filter
US7867275B2 (en) *	1995-06-07	2011-01-11	Cook Incorporated	Coated implantable medical device method
US6774278B1 (en) *	1995-06-07	2004-08-10	Cook Incorporated	Coated implantable medical device
US5942241A (en)	1995-06-09	1999-08-24	Euro-Celtique, S.A.	Formulations and methods for providing prolonged local anesthesia
BR9710646A (pt) *	1996-03-12	2000-01-11	Pg Txl Co Lp	Pródrogas de paclitaxel solúveis em água.
US6441025B2 (en)	1996-03-12	2002-08-27	Pg-Txl Company, L.P.	Water soluble paclitaxel derivatives
AU775787B2 (en) *	1996-05-24	2004-08-12	Angiotech Pharmaceuticals, Inc.	Compositions and methods for treating or preventing diseases of body passageways
WO1997045105A1 (en) *	1996-05-24	1997-12-04	Angiotech Pharmaceuticals, Inc.	Compositions and methods for treating or preventing diseases of body passageways
US6143037A (en) *	1996-06-12	2000-11-07	The Regents Of The University Of Michigan	Compositions and methods for coating medical devices
EP0954301A4 (en)	1996-06-24	2006-03-08	Euro Celtique Sa	SAFE METHODS OF LOCAL ANESTHESIA
US7351421B2 (en) *	1996-11-05	2008-04-01	Hsing-Wen Sung	Drug-eluting stent having collagen drug carrier chemically treated with genipin
US6495579B1 (en)	1996-12-02	2002-12-17	Angiotech Pharmaceuticals, Inc.	Method for treating multiple sclerosis
US6515016B2 (en)	1996-12-02	2003-02-04	Angiotech Pharmaceuticals, Inc.	Composition and methods of paclitaxel for treating psoriasis
US20050043376A1 (en) *	1996-12-03	2005-02-24	Danishefsky Samuel J.	Synthesis of epothilones, intermediates thereto, analogues and uses thereof
US6867305B2 (en) *	1996-12-03	2005-03-15	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
US6204388B1 (en) *	1996-12-03	2001-03-20	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
EP1386922B1 (en)	1996-12-03	2012-04-11	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereof, analogues and uses thereof
IL131701A (en)	1997-03-11	2005-03-20	Aeterna Zentaris Inc	Compositions for treating tumors containing shark cartilage extracts and anti-neoplastic agents
US6511477B2 (en)	1997-03-13	2003-01-28	Biocardia, Inc.	Method of drug delivery to interstitial regions of the myocardium
US6273913B1 (en) *	1997-04-18	2001-08-14	Cordis Corporation	Modified stent useful for delivery of drugs along stent strut
US8853260B2 (en)	1997-06-27	2014-10-07	Abraxis Bioscience, Llc	Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
US20030199425A1 (en) *	1997-06-27	2003-10-23	Desai Neil P.	Compositions and methods for treatment of hyperplasia
WO1999008729A1 (en) *	1997-08-13	1999-02-25	Boston Scientific Limited	Loading and release of water-insoluble drugs
US6306166B1 (en) *	1997-08-13	2001-10-23	Scimed Life Systems, Inc.	Loading and release of water-insoluble drugs
DE69841984D1 (de) *	1997-09-05	2010-12-16	Maruho K K	Zusammensetzung aus nanokapseln zur behandlung von intraarticulaeren erkrankungen
DE19744135C1 (de) *	1997-09-29	1999-03-25	Schering Ag	Beschichtete medizinische Implantate, Verfahren zu ihrer Herstellung und ihre Verwendung zur Restenoseprophylaxe
US6485514B1 (en) *	1997-12-12	2002-11-26	Supergen, Inc.	Local delivery of therapeutic agents
KR20010086245A (ko)	1998-03-04	2001-09-10	다케다 야쿠힌 고교 가부시키가이샤	Ａⅱ 길항제용 서방성 제제, 그것의 제조 및 용도
US7208010B2 (en)	2000-10-16	2007-04-24	Conor Medsystems, Inc.	Expandable medical device for delivery of beneficial agent
US20040254635A1 (en)	1998-03-30	2004-12-16	Shanley John F.	Expandable medical device for delivery of beneficial agent
US7208011B2 (en)	2001-08-20	2007-04-24	Conor Medsystems, Inc.	Implantable medical device with drug filled holes
US6241762B1 (en)	1998-03-30	2001-06-05	Conor Medsystems, Inc.	Expandable medical device with ductile hinges
EP1174157B1 (en)	1998-04-27	2005-06-29	Surmodics Inc.	Bioactive agent release coating
US6168807B1 (en)	1998-07-23	2001-01-02	Les Laboratoires Aeterna Inc.	Low molecular weight components of shark cartilage, processes for their preparation and therapeutic uses thereof
CA2340652C (en)	1998-08-20	2013-09-24	Cook Incorporated	Coated implantable medical device comprising paclitaxel
AU5687199A (en) *	1998-08-24	2000-03-14	Global Vascular Concepts, Inc.	Use of anti-angiogenic agents for inhibiting vessel wall injury
US6293967B1 (en)	1998-10-29	2001-09-25	Conor Medsystems, Inc.	Expandable medical device with ductile hinges
WO2000032238A1 (en) *	1998-12-03	2000-06-08	Scimed Life Systems, Inc.	Stent having drug crystals thereon
WO2002085337A1 (en) *	2001-04-20	2002-10-31	The University Of British Columbia	Micellar drug delivery systems for hydrophobic drugs
US6120847A (en) *	1999-01-08	2000-09-19	Scimed Life Systems, Inc.	Surface treatment method for stent coating
US6419692B1 (en)	1999-02-03	2002-07-16	Scimed Life Systems, Inc.	Surface protection method for stents and balloon catheters for drug delivery
WO2000050016A2 (en) *	1999-02-23	2000-08-31	Angiotech Pharmaceuticals, Inc.	Compositions and methods for improving integrity of compromised body passageways and cavities
US20020058286A1 (en) *	1999-02-24	2002-05-16	Danishefsky Samuel J.	Synthesis of epothilones, intermediates thereto and analogues thereof
AU3759100A (en) *	1999-03-24	2000-10-09	B.F. Goodrich Company, The	Inhibition of matrix metalloproteinases with polymers and pharmaceutical applications thereof
US6156373A (en)	1999-05-03	2000-12-05	Scimed Life Systems, Inc.	Medical device coating methods and devices
US6290673B1 (en)	1999-05-20	2001-09-18	Conor Medsystems, Inc.	Expandable medical device delivery system and method
EP1185312B1 (en) *	1999-05-27	2005-03-23	Monsanto Company	Biomaterials modified with superoxide dismutase mimics
US20040110722A1 (en) *	1999-05-27	2004-06-10	Ornberg Richard L.	Modified hyaluronic acid polymers
US6258121B1 (en) *	1999-07-02	2001-07-10	Scimed Life Systems, Inc.	Stent coating
DE29911689U1 (de) *	1999-07-06	2000-04-06	Sterk, Peter, Dr., 88212 Ravensburg	Mittel für den Gefässverschluß von organischem Gewebe
US7687462B2 (en)	1999-10-05	2010-03-30	The Regents Of The University Of California	Composition for promoting cartilage formation or repair comprising a nell gene product and method of treating cartilage-related conditions using such composition
EP1235598A2 (en) *	1999-11-12	2002-09-04	Angiotech Pharmaceuticals, Inc.	Compositions of a combination of radioactive therapy and cell-cycle inhibitors
WO2001047451A1 (en) *	1999-12-29	2001-07-05	Gishel New	Apparatus and method for delivering compounds to a living organism
JP2003525243A (ja) *	2000-02-28	2003-08-26	ザユニバーシティオブブリティッシュコロンビア	炎症性疾患の治療のための組成物及び方法
JP2003525682A (ja) *	2000-03-06	2003-09-02	シメッドライフシステムズインコーポレイテッド	超音波下で目視できる塞栓剤
US20020077290A1 (en)	2000-03-17	2002-06-20	Rama Bhatt	Polyglutamic acid-camptothecin conjugates and methods of preparation
DK1312635T3 (da) *	2000-03-18	2005-10-17	Polyzenix Gmbh	Tandimplantater med antibakterielle egenskaber
CN101708165A (zh) *	2000-03-24	2010-05-19	生物领域医疗公司	用于主动栓塞术的微球体
WO2001072280A2 (en) *	2000-03-24	2001-10-04	Biosphere Medical Inc.	Microspheres for gene therapy
US20030212022A1 (en) *	2001-03-23	2003-11-13	Jean-Marie Vogel	Compositions and methods for gene therapy
DE10191512D2 (de)	2000-04-11	2003-03-13	Univ Heidelberg	Umhüllungen und Folien aus Poly-Tri-Fluor-Ethoxypolyphosphazen
EP1179353A1 (de) *	2000-08-11	2002-02-13	B. Braun Melsungen Ag	Antithrombogene Implantate mit Beschichtung aus Polyphosphazenen und einem pharmakologisch aktiven Wirkstoff
US20090004240A1 (en) *	2000-08-11	2009-01-01	Celonova Biosciences, Inc.	Implants with a phosphazene-containing coating
EP1313415B1 (en)	2000-08-30	2008-08-13	Johns Hopkins University	Devices for intraocular drug delivery
US7101391B2 (en) *	2000-09-18	2006-09-05	Inflow Dynamics Inc.	Primarily niobium stent
US7402173B2 (en) *	2000-09-18	2008-07-22	Boston Scientific Scimed, Inc.	Metal stent with surface layer of noble metal oxide and method of fabrication
JP5100951B2 (ja) †	2000-09-29	2012-12-19	コーディス・コーポレイション	被覆医用器具
US6764507B2 (en)	2000-10-16	2004-07-20	Conor Medsystems, Inc.	Expandable medical device with improved spatial distribution
DE60133053T2 (de)	2000-10-16	2009-02-26	Conor Medsystems, Inc., Menlo Park	Ausdehnbare medizinische Vorrichtung zur Abgabe eines nützlichen Agens
US7776310B2 (en) *	2000-11-16	2010-08-17	Microspherix Llc	Flexible and/or elastic brachytherapy seed or strand
US6746661B2 (en) *	2000-11-16	2004-06-08	Microspherix Llc	Brachytherapy seed
US7425217B2 (en)	2000-11-16	2008-09-16	Maier Nathan C	System and method for inhibiting cellular proliferation with tachykinins
EP1372742A2 (en) *	2000-11-16	2004-01-02	Microspherix LLC	Polymeric imagable brachytherapy seed
EP1335760B1 (de)	2000-11-21	2006-08-30	Schering Aktiengesellschaft	Röhrenförmige gefässimplantate (stents) sowie verfahren zu deren herstellung
GB0100761D0 (en) *	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
GB0100760D0 (en)	2001-01-11	2001-02-21	Biocompatibles Ltd	Drug delivery from stents
DE10100961B4 (de) *	2001-01-11	2005-08-04	Polyzenix Gmbh	Körperverträglicher Werkstoff und mit diesem Werkstoff beschichtetes Substrat für die Züchtung von Zellen und künstlichen aus Zellen aufgebauten oder gewachsenen organischen Implantaten
WO2003015719A1 (de) *	2001-08-17	2003-02-27	Polyzenix Gmbh	Vorrichtung auf basis von nitinol mit polyphosphazenüberzug
US9080146B2 (en)	2001-01-11	2015-07-14	Celonova Biosciences, Inc.	Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20020176893A1 (en) *	2001-02-02	2002-11-28	Wironen John F.	Compositions, implants, methods, and kits for closure of lumen openings, repair of ruptured tissue, and for bulking of tissue
US6685626B2 (en)	2001-02-02	2004-02-03	Regeneration Technologies, Inc.	Compositions, devices, methods, and kits for induction of adhesions
US6964680B2 (en)	2001-02-05	2005-11-15	Conor Medsystems, Inc.	Expandable medical device with tapered hinge
US20040073294A1 (en) *	2002-09-20	2004-04-15	Conor Medsystems, Inc.	Method and apparatus for loading a beneficial agent into an expandable medical device
US20040204756A1 (en) *	2004-02-11	2004-10-14	Diaz Stephen Hunter	Absorbent article with improved liquid acquisition capacity
GB0104383D0 (en)	2001-02-22	2001-04-11	Psimedica Ltd	Cancer Treatment
CA2440935A1 (en)	2001-03-13	2002-09-19	Richard Liggins	Micellar drug delivery vehicles and precursors thereto and uses thereof
US7771468B2 (en)	2001-03-16	2010-08-10	Angiotech Biocoatings Corp.	Medicated stent having multi-layer polymer coating
DE10115740A1 (de)	2001-03-26	2002-10-02	Ulrich Speck	Zubereitung für die Restenoseprophylaxe
US20040185101A1 (en) *	2001-03-27	2004-09-23	Macromed, Incorporated.	Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
US20030157161A1 (en) *	2001-05-01	2003-08-21	Angiotech Pharmaceuticals, Inc.	Compositions and methods for treating inflammatory conditions utilizing protein or polysaccharide containing anti-microtubule agents
US6613083B2 (en)	2001-05-02	2003-09-02	Eckhard Alt	Stent device and method
US7651695B2 (en)	2001-05-18	2010-01-26	Advanced Cardiovascular Systems, Inc.	Medicated stents for the treatment of vascular disease
US20030032935A1 (en) *	2001-08-10	2003-02-13	Scimed Life Systems, Inc.	Packages facilitating convenient mixing and delivery of liquids
US20040249443A1 (en) *	2001-08-20	2004-12-09	Shanley John F.	Expandable medical device for treating cardiac arrhythmias
US7842083B2 (en)	2001-08-20	2010-11-30	Innovational Holdings, Llc.	Expandable medical device with improved spatial distribution
US7056338B2 (en)	2003-03-28	2006-06-06	Conor Medsystems, Inc.	Therapeutic agent delivery device with controlled therapeutic agent release rates
US20040121981A1 (en) *	2001-11-21	2004-06-24	Glycogenesys, Inc.	Method for controlling angiogenesis in animals
US20030181810A1 (en)	2002-03-25	2003-09-25	Murphy Kieran P.	Kit for image guided surgical procedures
US9375203B2 (en)	2002-03-25	2016-06-28	Kieran Murphy Llc	Biopsy needle
US7927368B2 (en)	2002-03-25	2011-04-19	Kieran Murphy Llc	Device viewable under an imaging beam
US7462366B2 (en)	2002-03-29	2008-12-09	Boston Scientific Scimed, Inc.	Drug delivery particle
US7094369B2 (en)	2002-03-29	2006-08-22	Scimed Life Systems, Inc.	Processes for manufacturing polymeric microspheres
US7131997B2 (en)	2002-03-29	2006-11-07	Scimed Life Systems, Inc.	Tissue treatment
US7053134B2 (en)	2002-04-04	2006-05-30	Scimed Life Systems, Inc.	Forming a chemically cross-linked particle of a desired shape and diameter
US20040038303A1 (en) *	2002-04-08	2004-02-26	Unger Gretchen M.	Biologic modulations with nanoparticles
KR100995225B1 (ko)	2002-04-22	2010-11-17	재단법인 이쯔우 연구소	혈관성 질환의 치료를 위한 의약
NZ536308A (en) *	2002-05-24	2009-01-31	Angiotech Int Ag	Compositions and methods for coating medical implants
US8313760B2 (en)	2002-05-24	2012-11-20	Angiotech International Ag	Compositions and methods for coating medical implants
CZ294371B6 (cs) *	2002-06-10	2004-12-15	Pliva - Lachema, A. S.	Stabilizovaná farmaceutická kompozice na bázi polyoxyethylovaného ricinového oleje a způsob její přípravy
US7649023B2 (en)	2002-06-11	2010-01-19	Novartis Ag	Biodegradable block copolymeric compositions for drug delivery
US20040037887A1 (en)	2002-06-12	2004-02-26	Scimed Life Systems, Inc.	Bulking agent
US7097850B2 (en) *	2002-06-18	2006-08-29	Surmodics, Inc.	Bioactive agent release coating and controlled humidity method
US20030232087A1 (en) *	2002-06-18	2003-12-18	Lawin Laurie R.	Bioactive agent release coating with aromatic poly(meth)acrylates
CN100346850C (zh) *	2003-05-28	2007-11-07	微创医疗器械(上海)有限公司	一种药物涂层支架
US20080138377A1 (en) *	2002-07-05	2008-06-12	Celonova Biosciences, Inc.	Vasodilator Eluting Luminal Stent Devices With A Specific Polyphosphazene Coating and Methods for Their Manufacture and Use
US20080138433A1 (en) *	2002-07-05	2008-06-12	Celonova Biosciences, Inc.	Vasodilator eluting blood storage and administration devices with a specific polyphosphazene coating and methods for their manufacture and use
EP1521603B1 (en)	2002-07-12	2011-01-19	Cook Incorporated	Coated medical device
US20050163821A1 (en) *	2002-08-02	2005-07-28	Hsing-Wen Sung	Drug-eluting Biodegradable Stent and Delivery Means
US7449236B2 (en)	2002-08-09	2008-11-11	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US7842377B2 (en) *	2003-08-08	2010-11-30	Boston Scientific Scimed, Inc.	Porous polymeric particle comprising polyvinyl alcohol and having interior to surface porosity-gradient
US20040076582A1 (en) *	2002-08-30	2004-04-22	Dimatteo Kristian	Agent delivery particle
US6921769B2 (en)	2002-08-23	2005-07-26	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
DE60310916T2 (de) *	2002-08-23	2007-11-15	Sloan-Kettering Institute For Cancer Research	Synthese von epothilonen, zwischenprodukte dafür, analoga und deren verwendungen
US7649006B2 (en)	2002-08-23	2010-01-19	Sloan-Kettering Institute For Cancer Research	Synthesis of epothilones, intermediates thereto and analogues thereof
US8012454B2 (en)	2002-08-30	2011-09-06	Boston Scientific Scimed, Inc.	Embolization
JP3887588B2 (ja) *	2002-08-30	2007-02-28	株式会社リガク	Ｘ線回折による応力測定法
JP2006511475A (ja) *	2002-09-18	2006-04-06	トラスティーズオブザユニバーシティオブペンシルベニア	脈絡膜新生血管症の抑制方法
DE10244847A1 (de)	2002-09-20	2004-04-01	Ulrich Prof. Dr. Speck	Medizinische Vorrichtung zur Arzneimittelabgabe
AU2003276920A1 (en) *	2002-09-20	2004-04-08	Innovational Holdings, Llc	Expandable medical device with openings for delivery of multiple beneficial agents
US20040127976A1 (en) *	2002-09-20	2004-07-01	Conor Medsystems, Inc.	Method and apparatus for loading a beneficial agent into an expandable medical device
CA2497349C (en) *	2002-09-26	2008-07-08	Angiotech International Ag	Perivascular wraps
SI1553938T1 (sl) *	2002-10-15	2007-06-30	Univ Louisiana State	Uporaba epotilonskih derivatov za zdravljenje hiperparatiroidizma
AU2003286502A1 (en) *	2002-10-21	2004-05-13	The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services	Contiguous capillary electrospray sources and analytical device
US7883490B2 (en)	2002-10-23	2011-02-08	Boston Scientific Scimed, Inc.	Mixing and delivery of therapeutic compositions
US7588825B2 (en)	2002-10-23	2009-09-15	Boston Scientific Scimed, Inc.	Embolic compositions
KR20050086440A (ko) *	2002-11-08	2005-08-30	코너 메드시스템즈, 인코포레이티드	허혈성 상해 후에 조직 손상을 감소시키기 위한 방법 및장치
US20040142014A1 (en) *	2002-11-08	2004-07-22	Conor Medsystems, Inc.	Method and apparatus for reducing tissue damage after ischemic injury
CA2505576A1 (en) *	2002-11-08	2004-05-27	Conor Medsystems, Inc.	Expandable medical device and method for treating chronic total occlusions with local delivery of an angiogenic factor
US20060121080A1 (en)	2002-11-13	2006-06-08	Lye Whye K	Medical devices having nanoporous layers and methods for making the same
US9770349B2 (en)	2002-11-13	2017-09-26	University Of Virginia Patent Foundation	Nanoporous stents with enhanced cellular adhesion and reduced neointimal formation
CN1725988A (zh)	2002-11-13	2006-01-25	斯特根有限公司	具有多孔层的医用装置及其制造方法
AU2003299590B8 (en)	2002-12-09	2010-04-08	Abraxis Bioscience, Llc	Compositions and methods of delivery of pharmacological agents
US7338557B1 (en) *	2002-12-17	2008-03-04	Advanced Cardiovascular Systems, Inc.	Nozzle for use in coating a stent
US7842791B2 (en)	2002-12-19	2010-11-30	Nancy Jean Britten	Dispersible pharmaceutical compositions
AU2004224772B2 (en) *	2003-03-26	2009-09-10	Celonova Biosciences Germany Gmbh	Coated dental implants
ATE526038T1 (de)	2003-03-28	2011-10-15	Innovational Holdings Llc	Implantierbares medizinprodukt mit kontinuierlichem mittel-konzentrationsgefälle
US20040202692A1 (en) *	2003-03-28	2004-10-14	Conor Medsystems, Inc.	Implantable medical device and method for in situ selective modulation of agent delivery
US20050010170A1 (en) *	2004-02-11	2005-01-13	Shanley John F	Implantable medical device with beneficial agent concentration gradient
EP1608289A2 (en) *	2003-03-28	2005-12-28	Kosan Biosciences, Inc.	Devices, methods, and compositions to prevent restenosis
US7306580B2 (en)	2003-04-16	2007-12-11	Cook Incorporated	Medical device with therapeutic agents
US20040220534A1 (en) *	2003-04-29	2004-11-04	Martens Paul W.	Medical device with antimicrobial layer
ATE476960T1 (de) *	2003-05-02	2010-08-15	Surmodics Inc	System zur kontrollierten freisetzung eines bioaktiven wirkstoffs im hinteren bereich des auges
US8246974B2 (en) *	2003-05-02	2012-08-21	Surmodics, Inc.	Medical devices and methods for producing the same
US7169179B2 (en)	2003-06-05	2007-01-30	Conor Medsystems, Inc.	Drug delivery device and method for bi-directional drug delivery
CA2535345A1 (en) *	2003-08-13	2005-03-03	Medtronic, Inc.	Active agent delivery systems including a miscible polymer blend, medical devices, and methods
WO2005018600A2 (en) *	2003-08-22	2005-03-03	Cube Medical A/S	Method of treating a patient suffering from a solid tumour
US7976823B2 (en)	2003-08-29	2011-07-12	Boston Scientific Scimed, Inc.	Ferromagnetic particles and methods
AU2004274026A1 (en) *	2003-09-18	2005-03-31	Macusight, Inc.	Transscleral delivery
US7785653B2 (en)	2003-09-22	2010-08-31	Innovational Holdings Llc	Method and apparatus for loading a beneficial agent into an expandable medical device
US7056337B2 (en) *	2003-10-21	2006-06-06	Cook Incorporated	Natural tissue stent
US7901770B2 (en)	2003-11-04	2011-03-08	Boston Scientific Scimed, Inc.	Embolic compositions
US20050100529A1 (en) *	2003-11-06	2005-05-12	Zeldis Jerome B.	Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of asbestos-related diseases and disorders
FR2861993B1 (fr) *	2003-11-06	2006-01-21	Jean Claude Rigaud	Complexe moleculaire anti restenose pour endoprothese intracoronaire
US20050181977A1 (en) *	2003-11-10	2005-08-18	Angiotech International Ag	Medical implants and anti-scarring agents
US20050100577A1 (en) *	2003-11-10	2005-05-12	Parker Theodore L.	Expandable medical device with beneficial agent matrix formed by a multi solvent system
US20050209664A1 (en) *	2003-11-20	2005-09-22	Angiotech International Ag	Electrical devices and anti-scarring agents
WO2005051444A2 (en) *	2003-11-20	2005-06-09	Angiotech International Ag	Soft tissue implants and anti-scarring agents
US20050208095A1 (en) *	2003-11-20	2005-09-22	Angiotech International Ag	Polymer compositions and methods for their use
ATE549044T1 (de) *	2003-12-24	2012-03-15	Novartis Pharma Gmbh	Vorrichtungen beschichtigt mit pek-polymere
CN1897930A (zh) *	2004-01-30	2007-01-17	血管技术国际股份公司	用于治疗挛缩的组合物和方法
US7349971B2 (en) *	2004-02-05	2008-03-25	Scenera Technologies, Llc	System for transmitting data utilizing multiple communication applications simultaneously in response to user request without specifying recipient's communication information
US7294145B2 (en) *	2004-02-26	2007-11-13	Boston Scientific Scimed, Inc.	Stent with differently coated inside and outside surfaces
US7736671B2 (en)	2004-03-02	2010-06-15	Boston Scientific Scimed, Inc.	Embolization
US8173176B2 (en)	2004-03-30	2012-05-08	Boston Scientific Scimed, Inc.	Embolization
US8003122B2 (en) *	2004-03-31	2011-08-23	Cordis Corporation	Device for local and/or regional delivery employing liquid formulations of therapeutic agents
WO2005099787A1 (en)	2004-04-06	2005-10-27	Surmodics, Inc.	Coating compositions for bioactive agents
US20060083772A1 (en) *	2004-04-06	2006-04-20	Dewitt David M	Coating compositions for bioactive agents
US20050238870A1 (en) *	2004-04-22	2005-10-27	Marcia Buiser	Embolization
EP1600121B1 (en) *	2004-05-25	2007-07-18	William Cook Europe ApS	Stent and stent retrieval system
US7311861B2 (en)	2004-06-01	2007-12-25	Boston Scientific Scimed, Inc.	Embolization
US20050287287A1 (en) *	2004-06-24	2005-12-29	Parker Theodore L	Methods and systems for loading an implantable medical device with beneficial agent
US20080280973A1 (en) *	2004-06-28	2008-11-13	Wender Paul A	Laulimalide Analogues as Therapeutic Agents
USD516723S1 (en)	2004-07-06	2006-03-07	Conor Medsystems, Inc.	Stent wall structure
WO2006017275A1 (en)	2004-07-13	2006-02-16	The University Of Tennessee Research Foundation	Adhesive composition for carrying therapeutic agents as delivery vehicle on coatings applied to vascular grafts
US8119153B2 (en) *	2004-08-26	2012-02-21	Boston Scientific Scimed, Inc.	Stents with drug eluting coatings
EP1799151A4 (en) *	2004-09-15	2014-09-17	Conor Medsystems Inc	BINDERSTAND WITH A CERPRINCIBLE END AND METHOD FOR STORING A STENT IN A BIFURCATION
EP1807018A4 (en) *	2004-10-21	2012-07-04	Univ Iowa Res Found	SYSTEM FOR CONTROLLED IN-SITU ADMINISTRATION OF MEDICINAL PRODUCTS
US9114162B2 (en)	2004-10-25	2015-08-25	Celonova Biosciences, Inc.	Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US9107850B2 (en)	2004-10-25	2015-08-18	Celonova Biosciences, Inc.	Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
US20210299056A9 (en)	2004-10-25	2021-09-30	Varian Medical Systems, Inc.	Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US20060093647A1 (en) *	2004-10-29	2006-05-04	Villafana Manuel A	Multiple layer coating composition
JP2008519036A (ja) *	2004-11-08	2008-06-05	バクスター・インターナショナル・インコーポレイテッド	チューブリン阻害化合物のナノ粒子組成物
US8425550B2 (en)	2004-12-01	2013-04-23	Boston Scientific Scimed, Inc.	Embolic coils
CA2596283C (en) *	2005-01-28	2011-11-01	Tepha, Inc.	Embolization using poly-4-hydroxybutyrate particles
EA012083B1 (ru) *	2005-02-03	2009-08-28	Синвеншен Аг	Материал для доставки лекарств, способ его получения и имплантат, содержащий этот материал
US9050393B2 (en)	2005-02-08	2015-06-09	Bruce N. Saffran	Medical devices and methods for modulation of physiology using device-based surface chemistry
AU2006213588B2 (en) *	2005-02-09	2011-11-17	Santen Pharmaceutical Co., Ltd.	Liquid formulations for treatment of diseases or conditions
US8663639B2 (en)	2005-02-09	2014-03-04	Santen Pharmaceutical Co., Ltd.	Formulations for treating ocular diseases and conditions
DK3248600T3 (da)	2005-02-18	2020-07-06	Abraxis Bioscience Llc	Kombinationer og måder til administration af terapeutiske stoffer og kombinationsterapi
US8735394B2 (en)	2005-02-18	2014-05-27	Abraxis Bioscience, Llc	Combinations and modes of administration of therapeutic agents and combination therapy
AU2005100176A4 (en) *	2005-03-01	2005-04-07	Gym Tv Pty Ltd	Garbage bin clip
US7727555B2 (en)	2005-03-02	2010-06-01	Boston Scientific Scimed, Inc.	Particles
US7858183B2 (en)	2005-03-02	2010-12-28	Boston Scientific Scimed, Inc.	Particles
US20060224170A1 (en) *	2005-03-30	2006-10-05	Michael Duff	Surgical marker clip and method for cholangiography
CN101203250B (zh)	2005-04-15	2013-03-20	界面生物公司	经由非共价相互作用递送生物活性剂的方法、组合物及成形物件
US7963287B2 (en)	2005-04-28	2011-06-21	Boston Scientific Scimed, Inc.	Tissue-treatment methods
JO3058B1 (ar)	2005-04-29	2017-03-15	Applied Molecular Evolution Inc	الاجسام المضادة لمضادات -اي ال-6,تركيباتها طرقها واستعمالاتها
WO2006119968A2 (en)	2005-05-09	2006-11-16	Biosphere Medical S.A.	Compositions and methods using microspheres and non-ionic contrast agents
US20060280787A1 (en) *	2005-06-14	2006-12-14	Baxter International Inc.	Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
US20070004973A1 (en) *	2005-06-15	2007-01-04	Tan Sharon M L	Tissue treatment methods
US20060286071A1 (en) *	2005-06-21	2006-12-21	Epstein Samuel J	Therapeutic pastes for medical device coating
US9463426B2 (en)	2005-06-24	2016-10-11	Boston Scientific Scimed, Inc.	Methods and systems for coating particles
US7736293B2 (en)	2005-07-22	2010-06-15	Biocompatibles Uk Limited	Implants for use in brachytherapy and other radiation therapy that resist migration and rotation
US8187159B2 (en)	2005-07-22	2012-05-29	Biocompatibles, UK	Therapeutic member including a rail used in brachytherapy and other radiation therapy
WO2007019439A2 (en) *	2005-08-04	2007-02-15	Angiotech International Ag	Block copolymer compositions and uses thereof
CA2620585C (en)	2005-08-31	2015-04-28	Abraxis Bioscience, Llc	Compositions comprising poorly water soluble pharmaceutical agents and antimicrobial agents
AU2006284657B2 (en) *	2005-08-31	2012-07-19	Abraxis Bioscience, Llc	Compositions and methods for preparation of poorly water soluble drugs with increased stability
US8192483B2 (en)	2005-10-06	2012-06-05	Kaneka Corporation	Stent to be placed in the living body
US8007509B2 (en)	2005-10-12	2011-08-30	Boston Scientific Scimed, Inc.	Coil assemblies, components and methods
RU2316290C2 (ru) *	2005-11-21	2008-02-10	Институт биохимии им. А.Н. Баха РАН	Сетчатый эндопротез для восстановительной хирургии
US8101197B2 (en)	2005-12-19	2012-01-24	Stryker Corporation	Forming coils
US8152839B2 (en)	2005-12-19	2012-04-10	Boston Scientific Scimed, Inc.	Embolic coils
US7947368B2 (en)	2005-12-21	2011-05-24	Boston Scientific Scimed, Inc.	Block copolymer particles
US7501179B2 (en)	2005-12-21	2009-03-10	Boston Scientific Scimed, Inc.	Block copolymer particles
CA2635797C (en)	2006-02-09	2015-03-31	Macusight, Inc.	Stable formulations, and methods of their preparation and use
CN100486560C (zh) *	2006-03-06	2009-05-13	济南康泉医药科技有限公司	一种含血管抑制剂的复方抗癌缓释注射剂
CN100464736C (zh) *	2006-03-17	2009-03-04	山东蓝金生物工程有限公司	同载抗代谢药物及其增效剂的抗癌缓释注射剂
ES2563288T3 (es)	2006-03-23	2016-03-14	Santen Pharmaceutical Co., Ltd	Rapamicina en dosis bajas para el tratamiento de enfermedades relacionadas con la permeabilidad vascular
US7993675B2 (en)	2006-05-10	2011-08-09	Medtronic Xomed, Inc.	Solvating system and sealant for medical use in the sinuses and nasal passages
KR100722607B1 (ko) *	2006-05-11	2007-05-28	주식회사 펩트론	분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
MX2008014953A (es) *	2006-05-26	2009-03-05	Bayer Healthcare Llc	Combinaciones de medicamentos con diarilureas sustituidas para el tratamiento de cancer.
US20070298069A1 (en) *	2006-06-26	2007-12-27	Boston Scientific Scimed, Inc.	Medical devices for release of low solubility therapeutic agents
US9023075B2 (en) *	2006-06-30	2015-05-05	Cvdevices, Llc	Devices, systems, and methods for lead delivery
AU2007275844B2 (en)	2006-06-30	2013-05-23	Cvdevices, Llc	Percutaneous intravascular access to cardiac tissue
WO2008134245A1 (en) *	2007-04-27	2008-11-06	Cvdevices, Llc	Devices, systems, and methods for promotion of infarct healing and reinforcement of border zone
US20080051702A1 (en) *	2006-08-24	2008-02-28	Herrmann Robert A	Therapeutic agent delivery for the treatment of asthma via implantable and insertable medical devices
JP2010505597A (ja)	2006-10-10	2010-02-25	セロノババイオサイエンシーズ，インコーポレイテッド	ポリホスファゼンを用いたバイオ人工心臓弁
AU2007307719A1 (en) *	2006-10-10	2008-04-17	Celonova Biosciences, Inc.	Compositions and devices comprising silicone and specific polyphosphazenes
US20080167592A1 (en) *	2006-10-26	2008-07-10	Greer Steven E	Preventing or treating wounds with a collodion barrier incorporating active agents
US8414927B2 (en)	2006-11-03	2013-04-09	Boston Scientific Scimed, Inc.	Cross-linked polymer particles
ES2421206T3 (es)	2006-11-09	2013-08-29	Alcon Research, Ltd.	Matriz de polímero insoluble en agua para el suministro de fármaco
BRPI0718658A2 (pt) *	2006-11-09	2013-11-19	Alcon Res Ltd	Tampão de pontos compreendendo uma matriz polimérica insolúvel em água.
US8414525B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US8425459B2 (en)	2006-11-20	2013-04-23	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US9737640B2 (en)	2006-11-20	2017-08-22	Lutonix, Inc.	Drug releasing coatings for medical devices
US8414526B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8414910B2 (en)	2006-11-20	2013-04-09	Lutonix, Inc.	Drug releasing coatings for medical devices
US20080175887A1 (en)	2006-11-20	2008-07-24	Lixiao Wang	Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
US8998846B2 (en)	2006-11-20	2015-04-07	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US20080276935A1 (en)	2006-11-20	2008-11-13	Lixiao Wang	Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US9700704B2 (en)	2006-11-20	2017-07-11	Lutonix, Inc.	Drug releasing coatings for balloon catheters
US20080171068A1 (en) *	2007-01-17	2008-07-17	Etcetera Llc	Antimicrobial, infection-control and odor-control film and film composite
DE102007003184A1 (de)	2007-01-22	2008-07-24	Orlowski, Michael, Dr.	Verfahren zur Beladung von strukturierten Oberflächen
WO2008097511A2 (en) *	2007-02-07	2008-08-14	Cook Incorporated	Medical device coatings for releasing a therapeutic agent at multiple rates
US8088095B2 (en)	2007-02-08	2012-01-03	Medtronic Xomed, Inc.	Polymeric sealant for medical use
AU2008223387B2 (en) *	2007-03-06	2014-03-06	Covidien Lp	Wound closure material
US9888924B2 (en) *	2007-03-06	2018-02-13	Covidien Lp	Wound closure material
US20100076489A1 (en) *	2007-03-06	2010-03-25	Joshua Stopek	Wound closure material
US11064964B2 (en)	2007-03-08	2021-07-20	Sync-Rx, Ltd	Determining a characteristic of a lumen by measuring velocity of a contrast agent
US11197651B2 (en)	2007-03-08	2021-12-14	Sync-Rx, Ltd.	Identification and presentation of device-to-vessel relative motion
US10716528B2 (en)	2007-03-08	2020-07-21	Sync-Rx, Ltd.	Automatic display of previously-acquired endoluminal images
JP5639764B2 (ja)	2007-03-08	2014-12-10	シンク−アールエックス，リミティド	運動する器官と共に使用するイメージング及びツール
US8781193B2 (en)	2007-03-08	2014-07-15	Sync-Rx, Ltd.	Automatic quantitative vessel analysis
US9629571B2 (en)	2007-03-08	2017-04-25	Sync-Rx, Ltd.	Co-use of endoluminal data and extraluminal imaging
WO2012176191A1 (en)	2011-06-23	2012-12-27	Sync-Rx, Ltd.	Luminal background cleaning
US9968256B2 (en)	2007-03-08	2018-05-15	Sync-Rx Ltd.	Automatic identification of a tool
US9375164B2 (en)	2007-03-08	2016-06-28	Sync-Rx, Ltd.	Co-use of endoluminal data and extraluminal imaging
US20080265343A1 (en) *	2007-04-26	2008-10-30	International Business Machines Corporation	Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
US9050064B2 (en) *	2007-04-27	2015-06-09	Cvdevices, Llc	Systems for engaging a bodily tissue and methods of using the same
US8540674B2 (en)	2007-04-27	2013-09-24	Cvdevices, Llc	Devices, systems, and methods for transeptal atrial puncture using an engagement catheter platform
JP5174891B2 (ja) *	2007-04-27	2013-04-03	シーヴィデヴァイシズ，エルエルシー	心臓の心外膜表面にアクセスするための装置、システム、および方法
CA2684079C (en) *	2007-04-27	2016-08-23	Cvdevices, Llc	Devices, systems, and methods for accessing the epicardial surface of the heart
BRPI0811530B1 (pt)	2007-05-14	2019-01-02	Research Foundation Of State Univ Of New York	composição compreendendo indutor(es) de resposta fisiológica à dispersão ácido decanóico, superfície, solução, método ex vivo de tratamento ou inibição da formação de um biofilme sobre uma superfície
US8147769B1 (en)	2007-05-16	2012-04-03	Abbott Cardiovascular Systems Inc.	Stent and delivery system with reduced chemical degradation
JP2008305262A (ja) *	2007-06-08	2008-12-18	Konica Minolta Business Technologies Inc	サーバ及びシンクライアント環境でのプリンタ紹介方法
US9192697B2 (en)	2007-07-03	2015-11-24	Hemoteq Ag	Balloon catheter for treating stenosis of body passages and for preventing threatening restenosis
WO2009036368A2 (en) *	2007-09-14	2009-03-19	Nitto Denko Corporation	Drug carriers
EP2050441A1 (en) *	2007-10-19	2009-04-22	Université Victor Segalen Bordeaux 2	Use of beta blocker for the manufacture of a medicament for the treatment of hemangiomas
FR2922452B1 (fr) *	2007-10-19	2010-01-22	Coatex Sas	Formulations de composes organoplatiniques en presence de polymeres associatifs, produits obtenus et leurs utilisations
US20090110730A1 (en) *	2007-10-30	2009-04-30	Celonova Biosciences, Inc.	Loadable Polymeric Particles for Marking or Masking Individuals and Methods of Preparing and Using the Same
JP2011510786A (ja) *	2008-02-05	2011-04-07	シーヴィデヴァイシズ，エルエルシー	操縦係合カテーテルの装置、システム、および方法
DE102008008263A1 (de)	2008-02-08	2009-08-13	Thomas Kuczera	Restenoseprophylaxe
KR20100135262A (ko) *	2008-03-19	2010-12-24	가부시키가이샤 모리모토이야쿠	동결건조방법 및 동결건조장치
CN102026634B (zh)	2008-04-10	2014-01-22	弗吉尼亚州立邦联大学	诱导肿瘤缺氧以治疗癌症
DE202008006190U1 (de)	2008-05-06	2008-07-17	Sellin, Lothar	Restenoseprophylaxe
DE202008007347U1 (de)	2008-05-31	2008-10-16	Orlowski, Benjamin Daniel	Kupfer Stent
ES2759373T3 (es)	2008-06-12	2020-05-08	Medtronic Xomed Inc	Producto para el tratamiento de heridas crónicas con un sistema extracelular de solvatación de sustancias poliméricas
US8188235B2 (en)	2008-06-18	2012-05-29	Pfizer Inc.	Antibodies to IL-6 and their uses
US20090319031A1 (en) *	2008-06-19	2009-12-24	Yunbing Wang	Bioabsorbable Polymeric Stent With Improved Structural And Molecular Weight Integrity
US9216152B2 (en)	2008-06-27	2015-12-22	Tepha, Inc.	Injectable delivery of microparticles and compositions therefore
AU2009266917B2 (en)	2008-07-03	2013-02-07	Vesseltek Biomedical, Llc	Controlled and localized release of retinoids to improve neointimal hyperplasia
WO2010024898A2 (en)	2008-08-29	2010-03-04	Lutonix, Inc.	Methods and apparatuses for coating balloon catheters
US8114429B2 (en)	2008-09-15	2012-02-14	Cv Ingenuity Corp.	Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US9198968B2 (en)	2008-09-15	2015-12-01	The Spectranetics Corporation	Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8128951B2 (en)	2008-09-15	2012-03-06	Cv Ingenuity Corp.	Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US8257722B2 (en)	2008-09-15	2012-09-04	Cv Ingenuity Corp.	Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
US20100070013A1 (en) *	2008-09-18	2010-03-18	Medtronic Vascular, Inc.	Medical Device With Microsphere Drug Delivery System
US8226603B2 (en)	2008-09-25	2012-07-24	Abbott Cardiovascular Systems Inc.	Expandable member having a covering formed of a fibrous matrix for intraluminal drug delivery
US8076529B2 (en)	2008-09-26	2011-12-13	Abbott Cardiovascular Systems, Inc.	Expandable member formed of a fibrous matrix for intraluminal drug delivery
US8049061B2 (en)	2008-09-25	2011-11-01	Abbott Cardiovascular Systems, Inc.	Expandable member formed of a fibrous matrix having hydrogel polymer for intraluminal drug delivery
US9186128B2 (en)	2008-10-01	2015-11-17	Covidien Lp	Needle biopsy device
US8968210B2 (en)	2008-10-01	2015-03-03	Covidien LLP	Device for needle biopsy with integrated needle protection
US9332973B2 (en)	2008-10-01	2016-05-10	Covidien Lp	Needle biopsy device with exchangeable needle and integrated needle protection
US11298113B2 (en)	2008-10-01	2022-04-12	Covidien Lp	Device for needle biopsy with integrated needle protection
US9782565B2 (en)	2008-10-01	2017-10-10	Covidien Lp	Endoscopic ultrasound-guided biliary access system
US11064903B2 (en)	2008-11-18	2021-07-20	Sync-Rx, Ltd	Apparatus and methods for mapping a sequence of images to a roadmap image
WO2013175472A2 (en) *	2012-05-21	2013-11-28	Sync-Rx, Ltd.	Co-use of endoluminal data and extraluminal imaging
US9974509B2 (en)	2008-11-18	2018-05-22	Sync-Rx Ltd.	Image super enhancement
US10362962B2 (en)	2008-11-18	2019-07-30	Synx-Rx, Ltd.	Accounting for skipped imaging locations during movement of an endoluminal imaging probe
US9095313B2 (en)	2008-11-18	2015-08-04	Sync-Rx, Ltd.	Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe
US9101286B2 (en)	2008-11-18	2015-08-11	Sync-Rx, Ltd.	Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points
US8855744B2 (en)	2008-11-18	2014-10-07	Sync-Rx, Ltd.	Displaying a device within an endoluminal image stack
US9144394B2 (en)	2008-11-18	2015-09-29	Sync-Rx, Ltd.	Apparatus and methods for determining a plurality of local calibration factors for an image
DE102009059070A1 (de)	2008-12-19	2010-07-01	Lothar Sellin	Medizinische Einrichtung und Verfahren zu ihrer Herstellung
EP2210584A1 (en) *	2009-01-27	2010-07-28	Bayer Schering Pharma Aktiengesellschaft	Stable polymeric composition comprising an epothilone and an amphiphilic block copolymer
WO2010093945A2 (en)	2009-02-13	2010-08-19	Glaukos Corporation	Uveoscleral drug delivery implant and methods for implanting the same
JP4782850B2 (ja) *	2009-02-24	2011-09-28	シャープ株式会社	画像データ処理装置
US7828996B1 (en) *	2009-03-27	2010-11-09	Abbott Cardiovascular Systems Inc.	Method for the manufacture of stable, nano-sized particles
EP2413901A4 (en) *	2009-03-30	2015-05-06	Cerulean Pharma Inc	POLYMER CONCRETE CONJUGATES, PARTICLES, COMPOSITIONS AND CORRESPONDING USES
WO2010114768A1 (en) *	2009-03-30	2010-10-07	Cerulean Pharma Inc.	Polymer-epothilone conjugates, particles, compositions, and related methods of use
WO2010114770A1 (en) *	2009-03-30	2010-10-07	Cerulean Pharma Inc.	Polymer-agent conjugates, particles, compositions, and related methods of use
EP2243501A1 (en)	2009-04-24	2010-10-27	Eurocor Gmbh	Shellac and paclitaxel coated catheter balloons
RU2404243C1 (ru) *	2009-04-27	2010-11-20	Учреждение Российской академии медицинских наук Российский онкологический научный центр имени Н.Н.Блохина РАМН	ПРИМЕНЕНИЕ КЛЕТОЧНОЙ ЛИНИИ МЕЛАНОМЫ КОЖИ ЧЕЛОВЕКА mel Cher В КАЧЕСТВЕ ПОЛОЖИТЕЛЬНОЙ МОДЕЛИ ВАСКУЛОГЕННОЙ МИМИКРИИ
MX342897B (es)	2009-04-28	2016-10-18	Surmodics Inc	Dispositivos y metodos para suministrar agentes bioactivos.
DE202009006632U1 (de)	2009-05-07	2009-07-16	Sellin, Lothar	Beschichtung von medizinischen Oberflächen
US20100285085A1 (en) *	2009-05-07	2010-11-11	Abbott Cardiovascular Systems Inc.	Balloon coating with drug transfer control via coating thickness
WO2012071476A2 (en)	2010-11-24	2012-05-31	David Haffner	Drug eluting ocular implant
JP5937004B2 (ja)	2009-05-18	2016-06-22	ドーズメディカルコーポレーションＤｏｓｅＭｅｄｉｃａｌＣｏｒｐｏｒａｔｉｏｎ	薬剤溶出眼内インプラント
US10206813B2 (en)	2009-05-18	2019-02-19	Dose Medical Corporation	Implants with controlled drug delivery features and methods of using same
AU2010249558A1 (en) *	2009-05-20	2011-12-08	Arsenal Medical, Inc.	Medical implant
US20110319987A1 (en)	2009-05-20	2011-12-29	Arsenal Medical	Medical implant
US9309347B2 (en)	2009-05-20	2016-04-12	Biomedical, Inc.	Bioresorbable thermoset polyester/urethane elastomers
US8888840B2 (en) *	2009-05-20	2014-11-18	Boston Scientific Scimed, Inc.	Drug eluting medical implant
US9265633B2 (en)	2009-05-20	2016-02-23	480 Biomedical, Inc.	Drug-eluting medical implants
US8992601B2 (en)	2009-05-20	2015-03-31	480 Biomedical, Inc.	Medical implants
ES2550634T3 (es)	2009-07-10	2015-11-11	Boston Scientific Scimed, Inc.	Uso de nanocristales para un balón de suministro de fármaco
WO2011008393A2 (en)	2009-07-17	2011-01-20	Boston Scientific Scimed, Inc.	Nucleation of drug delivery balloons to provide improved crystal size and density
US8372133B2 (en) *	2009-10-05	2013-02-12	480 Biomedical, Inc.	Polymeric implant delivery system
EP2488172A4 (en)	2009-10-13	2014-08-13	Univ Michigan	DENDRIMER COMPOSITION AND METHOD FOR THEIR SYNTHESIS
DE202009014776U1 (de)	2009-11-02	2010-03-11	Sellin, Lothar	Beschichtung
EP2498764B1 (en)	2009-11-09	2017-09-06	Spotlight Technology Partners LLC	Fragmented hydrogels
NZ599524A (en)	2009-11-09	2014-04-30	Spotlight Technology Partners Llc	Polysaccharide based hydrogels
CA3037168A1 (en)	2009-12-18	2011-06-23	Interface Biologics, Inc.	Local delivery of drugs from self assembled coatings
DE202009017490U1 (de)	2009-12-22	2010-04-08	Sellin, Lothar	Weihrauch- und/oder Boswelliasäuren Beschichtung
RU2431481C1 (ru) *	2010-01-11	2011-10-20	Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Саратовский Государственный Аграрный Университет Имени Н.И. Вавилова"	Лекарственный препарат для лечения ран у животных
US20110218606A1 (en) *	2010-03-02	2011-09-08	Medtronic Vascular, Inc.	Methods for Stabilizing Femoral Vessels
US20110224720A1 (en) *	2010-03-11	2011-09-15	Cvdevices, Llc	Devices, systems, and methods for closing a hole in cardiac tissue
WO2011119536A1 (en)	2010-03-22	2011-09-29	Abbott Cardiovascular Systems Inc.	Stent delivery system having a fibrous matrix covering with improved stent retention
KR20130028727A (ko)	2010-03-29	2013-03-19	아브락시스 바이오사이언스, 엘엘씨	치료제의 약물 전달 및 유효성 향상 방법
ES2600912T3 (es)	2010-03-29	2017-02-13	Abraxis Bioscience, Llc	Métodos para tratar el cáncer
US10413506B2 (en)	2010-04-03	2019-09-17	Praful Doshi	Medical devices including medicaments and methods of making and using same including enhancing comfort, enhancing drug penetration, and treatment of myopia
US9554888B2 (en) *	2010-04-20	2017-01-31	University Of Utah Research Foundation	Phase separation sprayed scaffold
EP2571526B1 (en)	2010-05-17	2019-03-13	Novaer Holdings, Inc.	Drug delivery devices for delivery of ocular therapeutic agents
US8945156B2 (en)	2010-05-19	2015-02-03	University Of Utah Research Foundation	Tissue fixation
US8858577B2 (en)	2010-05-19	2014-10-14	University Of Utah Research Foundation	Tissue stabilization system
BR112012030699A2 (pt) *	2010-06-02	2016-09-13	Abraxis Bioscience Llc	métodos para tratar câncer de bexiga
NZ604031A (en)	2010-06-04	2015-05-29	Abraxis Bioscience Llc	Methods of treatment of pancreatic cancer
US8889211B2 (en)	2010-09-02	2014-11-18	Boston Scientific Scimed, Inc.	Coating process for drug delivery balloons using heat-induced rewrap memory
US8884027B2 (en)	2010-10-22	2014-11-11	University Of Rochester	Melampomagnolide B derivatives as antileukemic and cytotoxic agents
CN103249422A (zh)	2010-12-02	2013-08-14	丸善制药株式会社	Tie2活化剂、血管内皮生长因子抑制剂、血管生成抑制剂、血管成熟剂、血管正常化剂及血管稳定剂、以及药物组合物
AU2012210256B2 (en) *	2011-01-28	2017-03-02	Abk Biomedical Incorporated	Radiopaque embolic particles
US8852214B2 (en)	2011-02-04	2014-10-07	University Of Utah Research Foundation	System for tissue fixation to bone
DE202011002713U1 (de)	2011-02-14	2011-04-14	Sellin, Lothar	Biologisch abbaubare medizinische Beschichtung und deren Verwendung
US9757497B2 (en)	2011-05-20	2017-09-12	Surmodics, Inc.	Delivery of coated hydrophobic active agent particles
US9861727B2 (en)	2011-05-20	2018-01-09	Surmodics, Inc.	Delivery of hydrophobic active agent particles
US10213529B2 (en)	2011-05-20	2019-02-26	Surmodics, Inc.	Delivery of coated hydrophobic active agent particles
US10245178B1 (en)	2011-06-07	2019-04-02	Glaukos Corporation	Anterior chamber drug-eluting ocular implant
RU2467705C1 (ru) *	2011-06-30	2012-11-27	ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ И СОЦИАЛЬНОГО РАЗВИТИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ (ФГУ "РНЦРХТ" Минздравсоцразвития России)	Способ лечения облитерирующего атеросклероза сосудов нижних конечностей
WO2013028208A1 (en)	2011-08-25	2013-02-28	Boston Scientific Scimed, Inc.	Medical device with crystalline drug coating
EP2574918B1 (de)	2011-09-28	2014-12-10	Mems Ag	Mikrothermisches Verfahren und Sensor zur Bestimmung physikalischer Gaseigenschaften
DE202011106744U1 (de)	2011-10-15	2011-11-11	Lothar Sellin	Bessere Bioverfügbarkeit von Shellac/Paclitaxel Beschichtungen
US20130197657A1 (en) *	2011-12-08	2013-08-01	Diana Anca	Central airway stent
US20130245759A1 (en) *	2012-03-09	2013-09-19	The Florida International University Board Of Trustees	Medical devices incorporating silicone nanoparticles, and uses thereof
US20130317622A1 (en) *	2012-05-25	2013-11-28	Antonio Sambusseti	Surgical method for grafting an artificial implant in a bladder and/or in a urethral or ureteral segment
MX351261B (es)	2012-06-01	2017-10-06	Surmodics Inc	Aparato y método para recubrir catéteres con globo.
US9827401B2 (en)	2012-06-01	2017-11-28	Surmodics, Inc.	Apparatus and methods for coating medical devices
JP6134789B2 (ja)	2012-06-26	2017-05-24	シンク−アールエックス，リミティド	管腔器官における流れに関連する画像処理
US9956385B2 (en)	2012-06-28	2018-05-01	The Spectranetics Corporation	Post-processing of a medical device to control morphology and mechanical properties
WO2014008875A1 (de)	2012-07-12	2014-01-16	Cardionovum Gmbh	Katheterballon, verfahren zur herstellung eines beschichteten katheterballons sowie verwendung des pharmakologischen wirkstoffs
US9427309B2 (en)	2012-07-30	2016-08-30	Conextions, Inc.	Soft tissue repair devices, systems, and methods
US10219804B2 (en)	2012-07-30	2019-03-05	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US11944531B2 (en)	2012-07-30	2024-04-02	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US10390935B2 (en)	2012-07-30	2019-08-27	Conextions, Inc.	Soft tissue to bone repair devices, systems, and methods
US11957334B2 (en)	2012-07-30	2024-04-16	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US11253252B2 (en)	2012-07-30	2022-02-22	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US10835241B2 (en)	2012-07-30	2020-11-17	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
CN107043561B (zh)	2012-10-29	2019-10-11	阿里斯特医疗有限责任公司	聚合物涂料组合物和涂覆的产品
US9555119B2 (en)	2012-11-05	2017-01-31	Surmodics, Inc.	Composition and method for delivery of hydrophobic active agents
US11246963B2 (en)	2012-11-05	2022-02-15	Surmodics, Inc.	Compositions and methods for delivery of hydrophobic active agents
RU2528249C2 (ru) *	2012-11-23	2014-09-10	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Способ подавления ангиогенеза с помощью рекомбинантных форм урокиназы
US20140212355A1 (en) *	2013-01-28	2014-07-31	Abbott Cardiovascular Systems Inc.	Trans-arterial drug delivery
WO2014140684A1 (en) *	2013-03-15	2014-09-18	Microtech Medical Technologies Ltd.	Implantable anchor
DE202013002567U1 (de)	2013-03-18	2013-05-07	Lothar Sellin	NABP - Beschichtung
CN105188666A (zh)	2013-04-01	2015-12-23	阿勒根公司	用于持续的眼内释放的微球药物递送系统
US10842969B2 (en)	2013-10-25	2020-11-24	Mercator Medsystems, Inc.	Systems and methods of treating malacia by local delivery of hydrogel to augment tissue
EP3060143B1 (en) *	2013-10-25	2021-01-06	Mercator Medsystems, Inc.	Maintenance of bronchial patency by local delivery of cytotoxic, cytostatic, or anti-neoplastic agent
US10525171B2 (en)	2014-01-24	2020-01-07	The Spectranetics Corporation	Coatings for medical devices
WO2015138760A1 (en)	2014-03-12	2015-09-17	Conextions, Inc.	Soft tissue repair devices, systems, and methods
US11583384B2 (en)	2014-03-12	2023-02-21	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
CA2943182A1 (en)	2014-03-21	2015-09-24	University Of Pittsburgh - Of The Commonwealth System Of Higher Education	Methods for preparation of a terminally sterilized hydrogel derived from extracellular matrix
CN106471074A (zh)	2014-04-22	2017-03-01	阿里斯特医疗公司	用于施加药物递送聚合物涂料的方法和工艺
EP3677229A1 (en)	2014-05-29	2020-07-08	Glaukos Corporation	Implants with controlled drug delivery features
RU2555378C1 (ru) *	2014-07-10	2015-07-10	Вадим Викторович Евдокимов	Способ эндоскопической остановки и профилактики язвенных кровотечений из дефектов стенки 12-перстной кишки
KR20170054429A (ko)	2014-09-03	2017-05-17	제네세규스 인코포레이티드	치료용 나노입자 및 관련 조성물, 방법, 및 시스템
JP6826992B2 (ja)	2014-11-26	2021-02-10	エービーケーバイオメディカルインコーポレイテッドＡｂｋＢｉｏｍｅｄｉｃａｌＩｎｃ．	放射線塞栓粒子
WO2016093412A1 (ko) *	2014-12-10	2016-06-16	주식회사 에이치제이메디칼	경동맥 화학색전술에 적용되는 인산염완충용액(PBS) 또는 인산버퍼(Phosphate Buffer)가 함유된 젤라틴 스폰지 및 이의 제조방법
DE202015002048U1 (de)	2015-03-16	2015-09-24	Han Bock-Sun	Implantat
KR101620090B1 (ko)	2015-04-20	2016-05-12	주식회사 티젤바이오	약물전달 키트, 약물전달체 제조용 기구, 및 약물전달체 제조방법
SG10202103998RA (en) *	2015-06-18	2021-05-28	Acuitybio Corp	Implantable drug delivery compositions and methods of use thereof
KR101748120B1 (ko) *	2015-07-13	2017-06-16	서울대학교산학협력단	나노입자-유리체 기반 단백질 복합체를 유효성분으로 포함하는 혈관신생억제용 조성물 및 이의 용도
WO2017040853A1 (en)	2015-09-02	2017-03-09	Glaukos Corporation	Drug delivery implants with bi-directional delivery capacity
CA2998483C (en)	2015-09-16	2022-09-06	Dfb Soria, Llc	Delivery of drug nanoparticles and methods of use thereof
US11564833B2 (en)	2015-09-25	2023-01-31	Glaukos Corporation	Punctal implants with controlled drug delivery features and methods of using same
US11185361B2 (en)	2015-10-12	2021-11-30	Landy Toth	Controlled and precise treatment of cardiac tissues
CN108699522B (zh)	2016-01-13	2022-05-27	高等教育联邦系统-匹兹堡大学	血管细胞外基质水凝胶
EP3442479A1 (en)	2016-04-20	2019-02-20	Harold Alexander Heitzmann	Bioresorbable ocular drug delivery device
US11696822B2 (en)	2016-09-28	2023-07-11	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US10898446B2 (en)	2016-12-20	2021-01-26	Surmodics, Inc.	Delivery of hydrophobic active agents from hydrophilic polyether block amide copolymer surfaces
JP2020514359A (ja)	2017-03-15	2020-05-21	ディーエフビーソリアリミテッドライアビリティカンパニー	タキサンのナノ粒子を用いる皮膚悪性腫瘍処置のための局所療法
WO2019040335A1 (en)	2017-08-19	2019-02-28	University Of Rochester	MICHELOLID DERIVATIVES, PREPARATION METHODS AND THEIR USE AS ANTICANCER AND ANTI-INFLAMMATORY AGENTS
US11547397B2 (en)	2017-12-20	2023-01-10	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
US12102317B2 (en)	2017-12-20	2024-10-01	Conextions, Inc.	Devices, systems, and methods for repairing soft tissue and attaching soft tissue to bone
WO2019159062A1 (en)	2018-02-13	2019-08-22	Murphy Kieran P	Delivery system for delivering a drug depot to a target site under image guidance and methods and uses of same
EP3755236A4 (en)	2018-02-20	2021-11-17	Conextions, Inc.	DEVICES, SYSTEMS AND METHODS FOR REPAIRING SOFT TISSUE AND ATTACHING SOFT TISSUE TO A BONE
CN112165949A (zh)	2018-03-16	2021-01-01	Dfb索里亚有限责任公司	使用紫杉烷纳米颗粒治疗宫颈上皮内瘤变(cin)和宫颈癌的局部疗法
WO2019222843A1 (en)	2018-05-22	2019-11-28	Interface Biologics, Inc.	Compositions and methods for delivering drugs to a vessel wall
CN109224119B (zh) *	2018-10-30	2021-02-23	北京大学深圳医院	一种π共轭纳米自组装颗粒瘤内注射栓塞肿瘤血管抗癌剂
WO2020112816A1 (en)	2018-11-29	2020-06-04	Surmodics, Inc.	Apparatus and methods for coating medical devices
US11819590B2 (en)	2019-05-13	2023-11-21	Surmodics, Inc.	Apparatus and methods for coating medical devices
US12226552B2 (en)	2019-09-30	2025-02-18	Surmodics, Inc.	Active agent depots formed in situ
CN111388757B (zh) *	2020-03-21	2022-07-15	哈尔滨工程大学	一种采用螺旋镁丝制备的可降解镁基复合材料
WO2022133251A1 (en) *	2020-12-17	2022-06-23	Mobius Therapeutics, Llc	Injection apparatus and method of use
WO2025050106A1 (en) *	2023-08-31	2025-03-06	University Of Tennessee Research Foundation	Sustained release ocular implants
US20250144051A1 (en) *	2023-11-07	2025-05-08	Khan Sciences, Inc.	Colchicine for Treating Connective Tissue Disorders

Family Cites Families (252)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3016308A (en) *	1957-08-06	1962-01-09	Moore Business Forms Inc	Recording paper coated with microscopic capsules of coloring material, capsules and method of making
US3029188A (en)	1958-02-20	1962-04-10	Olin Mathieson	Gelatin adhesive pharmaceutical preparations
US3991527A (en)	1975-07-10	1976-11-16	Bates Abrasive Products, Inc.	Coated abrasive disc
US4042457A (en)	1975-11-10	1977-08-16	Rush-Presbyterian-St. Luke's Medical Center	Preparation of tissue invasion inhibitor and method of treatment utilizing the inhibitor
USRE30239E (en)	1975-11-10	1980-03-25		Cell proliferation and tissue invasion inhibitor
US4391797A (en)	1977-01-05	1983-07-05	The Children's Hospital Medical Center	Systems for the controlled release of macromolecules
US4176177A (en)	1978-11-16	1979-11-27	Rush-Presbyterian-St. Luke's Medical Center	Inhibition of bone resorption
US4416877A (en)	1979-02-13	1983-11-22	Symphar S.A.	Anti-atherosclerotic pharmaceutical compositions containing diphosphonate compounds
US4300244A (en)	1979-09-19	1981-11-17	Carbomedics, Inc.	Cardiovascular grafts
US4356261A (en)	1980-04-22	1982-10-26	Rush-Presbyterian-St. Luke's Medical Center	Anti-invasion factor containing cultures
US4531936A (en) *	1981-01-29	1985-07-30	Gordon Robert T	Device and method for the selective delivery of drugs to the myocardium
US4768523A (en)	1981-04-29	1988-09-06	Lifecore Biomedical, Inc.	Hydrogel adhesive
US4357312A (en)	1981-07-16	1982-11-02	The Children's Hospital Medical Center	Method of making prolonged release body
US4534899A (en) *	1981-07-20	1985-08-13	Lipid Specialties, Inc.	Synthetic phospholipid compounds
US5441745A (en)	1982-03-30	1995-08-15	Vestar, Inc.	Method of delivering micellular particles encapsulating chemotherapeutic agents to tumors in a body
US4542025A (en)	1982-07-29	1985-09-17	The Stolle Research And Development Corporation	Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4994443A (en)	1982-12-20	1991-02-19	The Children's Medical Center Corporation	Inhibition of angiogenesis
US5001116A (en)	1982-12-20	1991-03-19	The Children's Medical Center Corporation	Inhibition of angiogenesis
US4906474A (en)	1983-03-22	1990-03-06	Massachusetts Institute Of Technology	Bioerodible polyanhydrides for controlled drug delivery
US5286763A (en)	1983-03-22	1994-02-15	Massachusetts Institute Of Technology	Bioerodible polymers for drug delivery in bone
US4834755A (en) *	1983-04-04	1989-05-30	Pfizer Hospital Products Group, Inc.	Triaxially-braided fabric prosthesis
US4959358A (en)	1983-06-06	1990-09-25	Beth Israel Hospital Assn.	Drug administration
US4500676A (en)	1983-12-15	1985-02-19	Biomatrix, Inc.	Hyaluronate modified polymeric articles
GB8334484D0 (en)	1983-12-24	1984-02-01	Smith & Nephew Ass	Surgical dressing
US4591496A (en)	1984-01-16	1986-05-27	Massachusetts Institute Of Technology	Process for making systems for the controlled release of macromolecules
MX163953B (es)	1984-03-27	1992-07-03	Univ New Jersey Med	Procedimiento para preparar una matriz biodegradable a base de colageno
US4779806A (en)	1984-07-23	1988-10-25	Massachusetts Institute Of Technology	Ultrasonically modulated polymeric devices for delivering compositions
US4580568A (en) *	1984-10-01	1986-04-08	Cook, Incorporated	Percutaneous endovascular stent and method for insertion thereof
US4789501A (en)	1984-11-19	1988-12-06	The Curators Of The University Of Missouri	Glass microspheres
US5128326A (en)	1984-12-06	1992-07-07	Biomatrix, Inc.	Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
US4916219A (en)	1985-03-28	1990-04-10	University Of Iowa Research Foundation	Oligosaccharide heparin fragments as inhibitors of complement cascade
US4824436A (en) *	1985-04-09	1989-04-25	Harvey Wolinsky	Method for the prevention of restenosis
US4733665C2 (en)	1985-11-07	2002-01-29	Expandable Grafts Partnership	Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) *	1985-11-07	1992-04-07	Expandable Grafts Partnership	Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US4771042A (en)	1985-11-25	1988-09-13	The Upjohn Company	Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
GB8601100D0 (en)	1986-01-17	1986-02-19	Cosmas Damian Ltd	Drug delivery system
US4806621A (en)	1986-01-21	1989-02-21	Massachusetts Institute Of Technology	Biocompatible, bioerodible, hydrophobic, implantable polyimino carbonate article
EP0257091B1 (en) *	1986-02-24	1993-07-28	Robert E. Fischell	An intravascular stent and percutaneous insertion system
US4966890A (en)	1986-04-04	1990-10-30	Angiogenics, Ltd.	Method and composition for arresting angiogenesis and capillary, cell or membrane leakage
US4955878A (en) *	1986-04-04	1990-09-11	Biotechnology, Inc.	Kit for preventing or treating arterial dysfunction resulting from angioplasty procedures
US4746729A (en)	1986-07-30	1988-05-24	Kuettner Klaus E	Cartilage-derived leukocyte elastase-inhibitor
US4882168A (en)	1986-09-05	1989-11-21	American Cyanamid Company	Polyesters containing alkylene oxide blocks as drug delivery systems
GB2194885A (en)	1986-09-10	1988-03-23	Ephraim Kaplan	Pharmaceutical compositions containing vanadium
US4893623A (en)	1986-12-09	1990-01-16	Advanced Surgical Intervention, Inc.	Method and apparatus for treating hypertrophy of the prostate gland
CH673117A5 (xx)	1986-12-10	1990-02-15	Ajinomoto Kk
US5092885A (en)	1987-02-12	1992-03-03	The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services	Peptides with laminin activity
US5084441A (en)	1987-03-04	1992-01-28	Shaw Jack M	Acetylated low density lipoproteins: a delivery system to phagocytic cells for stimulating immunologic response and host resistance
US5041126A (en)	1987-03-13	1991-08-20	Cook Incorporated	Endovascular stent and delivery system
US4800882A (en) *	1987-03-13	1989-01-31	Cook Incorporated	Endovascular stent and delivery system
US4861627A (en)	1987-05-01	1989-08-29	Massachusetts Institute Of Technology	Preparation of multiwall polymeric microcapsules
US4808402A (en)	1987-05-29	1989-02-28	Northwestern University	Method and compositions for modulating neovascularization
NL8701337A (nl)	1987-06-09	1989-01-02	Sentron V O F	Substraat voorzien van een bloedcompatibel oppervlak, verkregen door koppeling aan het oppervlak van een fysiologisch aktieve stof met remmende invloed op de vorming van bloedstolsels en/of in staat om gevormde bloedstolsels af te breken, alsmede werkwijze ter vervaardiging van het substraat.
US5059211A (en) *	1987-06-25	1991-10-22	Duke University	Absorbable vascular stent
US4829099A (en)	1987-07-17	1989-05-09	Bioresearch, Inc.	Metabolically acceptable polyisocyanate adhesives
US5019379A (en)	1987-07-31	1991-05-28	Massachusetts Institute Of Technology	Unsaturated polyanhydrides
GB8720440D0 (en)	1987-08-28	1987-10-07	Smith & Nephew Ass	Curable compositions
US5001009A (en)	1987-09-02	1991-03-19	Sterilization Technical Services, Inc.	Lubricious hydrophilic composite coated on substrates
US5059189A (en)	1987-09-08	1991-10-22	E. R. Squibb & Sons, Inc.	Method of preparing adhesive dressings containing a pharmaceutically active ingredient
US4983395A (en)	1987-11-12	1991-01-08	Theratech Inc.	Device for administering an active agent to the skin or mucosa
ES2017808A6 (es) *	1988-01-19	1991-03-01	Moses Judah Folkman	Un metodo para prepara una composicion para inhibir el crecimiento indeseado o patologico de celulas o tejidos.
US5135919A (en) *	1988-01-19	1992-08-04	Children's Medical Center Corporation	Method and a pharmaceutical composition for the inhibition of angiogenesis
US5460817A (en)	1988-01-19	1995-10-24	Allied Colloids Ltd.	Particulate composition comprising a core of matrix polymer with active ingredient distributed therein
US5446070A (en)	1991-02-27	1995-08-29	Nover Pharmaceuticals, Inc.	Compositions and methods for topical administration of pharmaceutically active agents
US4942184A (en)	1988-03-07	1990-07-17	The United States Of America As Represented By The Department Of Health And Human Services	Water soluble, antineoplastic derivatives of taxol
US5157049A (en) *	1988-03-07	1992-10-20	The United States Of America As Represented By The Department Of Health & Human Services	Method of treating cancers sensitive to treatment with water soluble derivatives of taxol
JPH0722576B2 (ja)	1988-04-11	1995-03-15	三菱電機株式会社	磁気共鳴装置
ATE145337T1 (de)	1988-05-02	1996-12-15	Phanos Tech Inc	Verbindungen, zusammensetzungen und verfahren zum binden von bio-affektions-substanzen an oberflächenmembranen von bioteilchen
US4989601A (en) *	1988-05-02	1991-02-05	Medical Engineering & Development Institute, Inc.	Method, apparatus, and substance for treating tissue having neoplastic cells
US5096892A (en)	1988-05-27	1992-03-17	The Children's Medical Center Corporation	Arylsulfatase inhibition and potentiation of angiostatic steroids and heparin
US5100668A (en)	1988-06-14	1992-03-31	Massachusetts Institute Of Technology	Controlled release systems containing heparin and growth factors
JPH0643336B2 (ja)	1988-06-30	1994-06-08	呉羽化学工業株式会社	血管増殖抑制剤
DE3825374A1 (de) *	1988-07-26	1990-02-01	Schwendener Reto Dipl Apotheke	Komplex aus mindestens einer lipophilen saeure und mitoxantron und/oder bisantren
US4966605A (en)	1988-07-28	1990-10-30	Thieler William R	Method for opening and closing surgical wounds
JPH0255064A (ja) *	1988-08-03	1990-02-23	Toa O	カテーテルを用いた血管内血栓の血栓除去装置
US5213580A (en) *	1988-08-24	1993-05-25	Endoluminal Therapeutics, Inc.	Biodegradable polymeric endoluminal sealing process
US5019090A (en) *	1988-09-01	1991-05-28	Corvita Corporation	Radially expandable endoprosthesis and the like
US5053048A (en) *	1988-09-22	1991-10-01	Cordis Corporation	Thromboresistant coating
US5252713A (en) *	1988-09-23	1993-10-12	Neorx Corporation	Polymeric carriers for non-covalent drug conjugation
US4938763B1 (en)	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
US5091176A (en)	1988-11-02	1992-02-25	W. R. Grace & Co.-Conn.	Polymer-modified peptide drugs having enhanced biological and pharmacological activities
US5211657A (en) *	1988-11-07	1993-05-18	The United States Government As Represented By The Secretary Of The Department Of Health And Human Services	Laminin a chain deduced amino acid sequence, expression vectors and active synthetic peptides
LU87410A1 (fr) *	1988-12-20	1990-07-10	Cird	Composition cosmetique ou pharmaceutique contenant des microspheres de polymeres ou de corps gras chargees d'au moins un produit actif
US5086164A (en)	1989-01-10	1992-02-04	Repligen Corporation	Novel methods and compositions for treatment of angiogenic diseases
US5356630A (en)	1989-02-22	1994-10-18	Massachusetts Institute Of Technology	Delivery system for controlled release of bioactive factors
US4960790A (en)	1989-03-09	1990-10-02	University Of Kansas	Derivatives of taxol, pharmaceutical compositions thereof and methods for the preparation thereof
US4905694A (en)	1989-04-04	1990-03-06	Ethicon, Inc.	Intracorporeal temporary wound closure
WO1990013332A1 (en) *	1989-05-11	1990-11-15	Cedars-Sinai Medical Center	Stent with sustained drug delivery
JP2877509B2 (ja) *	1989-05-19	1999-03-31	アムジエン・インコーポレーテツド	メタロプロテイナーゼ阻害剤
US5132315A (en)	1989-05-19	1992-07-21	The United States Of America As Represented By The Department Of Health And Human Services	Therapeutic application of an anti-invasive compound
US4990155A (en) *	1989-05-19	1991-02-05	Wilkoff Howard M	Surgical stent method and apparatus
US5171262A (en)	1989-06-15	1992-12-15	Cordis Corporation	Non-woven endoprosthesis
CA2015946A1 (en) *	1989-06-27	1990-12-27	Lawrence P. Klemann	Diol lipid analogues as edible fat replacements
US5290807A (en)	1989-08-10	1994-03-01	Children's Medical Center Corporation	Method for regressing angiogenesis using o-substituted fumagillol derivatives
EP0415294A3 (en)	1989-08-31	1991-06-12	Takeda Chemical Industries, Ltd.	Cyclohexanol derivatives, production and use thereof
CA1340994C (en) *	1989-09-21	2000-05-16	Rudolf Edgar Dr. Falk	Treatment of conditions and disease
JPH03109324A (ja)	1989-09-22	1991-05-09	Microbial Chem Res Found	血管新生阻害剤
US5461081A (en)	1989-09-28	1995-10-24	Alcon Laboratories, Inc.	Topical ophthalmic pharmaceutical vehicles
US5525348A (en)	1989-11-02	1996-06-11	Sts Biopolymers, Inc.	Coating compositions comprising pharmaceutical agents
US5120548A (en)	1989-11-07	1992-06-09	Merck & Co., Inc.	Swelling modulated polymeric drug delivery device
US5527532A (en)	1989-11-13	1996-06-18	President And Fellows Of Harvard College	Extraluminal regulation of the growth and repair of tubular structures in vivo
WO1991007154A1 (en)	1989-11-13	1991-05-30	President And Fellows Of Harvard College	EXTRALUMINAL REGULATION OF THE GROWTH AND REPAIR OF TUBULAR STRUCTURES ιIN VIVO
US5059166A (en) *	1989-12-11	1991-10-22	Medical Innovative Technologies R & D Limited Partnership	Intra-arterial stent with the capability to inhibit intimal hyperplasia
US5176617A (en) *	1989-12-11	1993-01-05	Medical Innovative Technologies R & D Limited Partnership	Use of a stent with the capability to inhibit malignant growth in a vessel such as a biliary duct
US5304121A (en) *	1990-12-28	1994-04-19	Boston Scientific Corporation	Drug delivery system making use of a hydrogel polymer coating
US5439446A (en) *	1994-06-30	1995-08-08	Boston Scientific Corporation	Stent and therapeutic delivery system
US5049132A (en) *	1990-01-08	1991-09-17	Cordis Corporation	Balloon catheter for delivering therapeutic agents
US5192744A (en) *	1990-01-12	1993-03-09	Northwestern University	Method of inhibiting angiogenesis of tumors
JPH06509791A (ja) *	1990-01-25	1994-11-02	チルドレンズ　ホスピタル	血管形成抑制のための方法と組成物
DK0441516T3 (da)	1990-02-08	1995-06-12	Howmedica	Oppusteligt kateter
US5075112A (en)	1990-02-12	1991-12-24	Cartilage Technologies Inc.	Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5200397A (en)	1990-02-22	1993-04-06	W. R. Grace & Co.-Conn.	Use of peptide analogs of thrombospondin for the inhibition of angiogenic activity
JPH05502179A (ja)	1990-02-28	1993-04-22	メドトロニック　インコーポレーテッド	管状器官内薬剤溶出装具
US5545208A (en) *	1990-02-28	1996-08-13	Medtronic, Inc.	Intralumenal drug eluting prosthesis
DE4006609A1 (de)	1990-03-02	1991-09-26	Max Planck Gesellschaft	Inhibitor der proliferation von endothelzellen
US5052998A (en)	1990-04-04	1991-10-01	Zimmon David S	Indwelling stent and method of use
US5290271A (en) *	1990-05-14	1994-03-01	Jernberg Gary R	Surgical implant and method for controlled release of chemotherapeutic agents
AU7909691A (en)	1990-05-14	1991-12-10	Gary R. Jernberg	Surgical implant and method incorporating chemotherapeutic agents
US5219564A (en)	1990-07-06	1993-06-15	Enzon, Inc.	Poly(alkylene oxide) amino acid copolymers and drug carriers and charged copolymers based thereon
US5092841A (en) *	1990-05-17	1992-03-03	Wayne State University	Method for treating an arterial wall injured during angioplasty
WO1991017724A1 (en) *	1990-05-17	1991-11-28	Harbor Medical Devices, Inc.	Medical device polymer
CA2083157A1 (en)	1990-05-18	1991-11-19	Richard S. Stack	Bioabsorbable stent
US5407683A (en)	1990-06-01	1995-04-18	Research Corporation Technologies, Inc.	Pharmaceutical solutions and emulsions containing taxol
JPH05507226A (ja) *	1990-06-15	1993-10-21	コートラック・メディカル・インコーポレーテッド	薬物投与装置および方法
US5462751A (en)	1990-06-22	1995-10-31	The Regeants Of The University Of California	Biological and pharmaceutical agents having a nanomeric biodegradable core
US5064435A (en)	1990-06-28	1991-11-12	Schneider (Usa) Inc.	Self-expanding prosthesis having stable axial length
EP0470569B1 (en) *	1990-08-08	1995-11-22	Takeda Chemical Industries, Ltd.	Intravascular embolizing agent containing angiogenesis inhibiting substance
JP3120187B2 (ja) *	1990-08-08	2000-12-25	武田薬品工業株式会社	血管新生阻害物質を含む血管内塞栓剤
US5210155A (en) *	1990-08-24	1993-05-11	Exxon Chemical Patents Inc.	Phenol terminated diester compositions derived from dicarboxylic acids, polyester polymers or alkyd polymers, and curable compositions containing same
US5278324A (en)	1990-08-28	1994-01-11	Virginia Tech Intellectual Properties, Inc.	Water soluble derivatives of taxol
NZ240214A (en)	1990-10-16	1993-02-25	Takeda Chemical Industries Ltd	Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
WO1992006701A1 (en)	1990-10-18	1992-04-30	Huffstutler, M., Conrad, Jr.	Preparation of concentrated fluid symphytum extracts, therapeutic forms and methods of use
AU8850391A (en) *	1990-10-18	1992-05-20	Ho Young Song	Self-expanding endovascular stent
CA2096520C (en)	1990-11-20	2000-12-19	Hiroshi Nakao	Therapeutic agent for skin or corneal disease
US5114953A (en)	1990-11-21	1992-05-19	University Of Florida	Treatment for tissue ulceration
US5268384A (en)	1990-11-21	1993-12-07	Galardy Richard E	Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
JP2928892B2 (ja)	1990-11-27	1999-08-03	三洋化成工業株式会社	外科用接着剤
US5149368A (en)	1991-01-10	1992-09-22	Liu Sung Tsuen	Resorbable bioactive calcium phosphate cement
US5540928A (en)	1991-02-27	1996-07-30	President And Fellows Of Harvard College	Extraluminal regulation of the growth and repair of tubular structures in vivo
WO1992015286A1 (en) *	1991-02-27	1992-09-17	Nova Pharmaceutical Corporation	Anti-infective and anti-inflammatory releasing systems for medical devices
US5171217A (en)	1991-02-28	1992-12-15	Indiana University Foundation	Method for delivery of smooth muscle cell inhibitors
KR0177492B1 (ko) *	1991-03-08	1999-05-01	케이지 이가키	맥관 스텐트, 맥관 스텐트 유지 구조체 및 맥관 스텐트 삽입 고착장치
AU650700B2 (en)	1991-03-08	1994-06-30	Keiji Igaki	Luminal stent, holding structure therefor and device for attaching luminal stent
IT1250421B (it)	1991-05-30	1995-04-07	Recordati Chem Pharm	Composizione farmaceutica a rilascio controllato con proprieta' bio-adesive.
US5147370A (en)	1991-06-12	1992-09-15	Mcnamara Thomas O	Nitinol stent for hollow body conduits
US5330768A (en)	1991-07-05	1994-07-19	Massachusetts Institute Of Technology	Controlled drug delivery using polymer/pluronic blends
FR2678833B1 (fr)	1991-07-08	1995-04-07	Rhone Poulenc Rorer Sa	Nouvelles compositions pharmaceutiques a base de derives de la classe des taxanes.
US5344644A (en)	1991-08-01	1994-09-06	Takeda Chemical Industries, Ltd.	Water-soluble composition for sustained-release
JPH0558882A (ja) *	1991-09-04	1993-03-09	Yoshiaki Kawashima	ナノカプセルの製造法
US5283253A (en)	1991-09-23	1994-02-01	Florida State University	Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5229526A (en)	1991-09-23	1993-07-20	Florida State University	Metal alkoxides
ATE187170T1 (de)	1991-09-23	1999-12-15	Univ Florida State	10-disacetoxytaxolderivate
US6515009B1 (en) *	1991-09-27	2003-02-04	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5811447A (en)	1993-01-28	1998-09-22	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
WO1993006792A1 (en) *	1991-10-04	1993-04-15	Scimed Life Systems, Inc.	Biodegradable drug delivery vascular stent
US5464450A (en)	1991-10-04	1995-11-07	Scimed Lifesystems Inc.	Biodegradable drug delivery vascular stent
CA2380683C (en) *	1991-10-28	2006-08-08	Advanced Cardiovascular Systems, Inc.	Expandable stents and method for making same
US5318780A (en)	1991-10-30	1994-06-07	Mediventures Inc.	Medical uses of in situ formed gels
JPH05131753A (ja) *	1991-11-15	1993-05-28	Fujicopian Co Ltd	多数回使用可能な熱転写インクシート
US5302397A (en)	1991-11-19	1994-04-12	Amsden Brian G	Polymer-based drug delivery system
US5270047A (en) *	1991-11-21	1993-12-14	Kauffman Raymond F	Local delivery of dipyridamole for the treatment of proliferative diseases
WO1993010076A1 (en)	1991-11-22	1993-05-27	The University Of Mississippi	Synthesis and optical resolution of the taxol side chain and related compounds
AU3221993A (en) *	1991-11-27	1993-06-28	Phanos Technologies, Inc.	Compounds, compositions and methods for binding bio-affecting substances to surface membranes of bio-particles
US5260002A (en)	1991-12-23	1993-11-09	Vanderbilt University	Method and apparatus for producing uniform polymeric spheres
CA2086642C (en)	1992-01-09	2004-06-15	Randall E. Morris	Method of treating hyperproliferative vascular disease
US5516781A (en)	1992-01-09	1996-05-14	American Home Products Corporation	Method of treating restenosis with rapamycin
US5176626A (en)	1992-01-15	1993-01-05	Wilson-Cook Medical, Inc.	Indwelling stent
US5260066A (en)	1992-01-16	1993-11-09	Srchem Incorporated	Cryogel bandage containing therapeutic agent
US6080777A (en)	1992-01-31	2000-06-27	The Trustees Of Columbia University In The City Of New York	Taxol as a radiation sensitizer
US5301664A (en)	1992-03-06	1994-04-12	Sievers Robert E	Methods and apparatus for drug delivery using supercritical solutions
US5200534A (en)	1992-03-13	1993-04-06	University Of Florida	Process for the preparation of taxol and 10-deacetyltaxol
EP0566245B1 (en)	1992-03-19	1999-10-06	Medtronic, Inc.	Intraluminal stent
US5474765A (en) *	1992-03-23	1995-12-12	Ut Sw Medical Ctr At Dallas	Preparation and use of steroid-polyanionic polymer-based conjugates targeted to vascular endothelial cells
WO1993018751A1 (en)	1992-03-23	1993-09-30	Georgetown University	Liposome encapsulated taxol and a method of using the same
KR100284210B1 (ko)	1992-04-28	2001-03-02	이건 이. 버그	과증식성 혈관 질환 치료용 배합 제제
US5461140A (en)	1992-04-30	1995-10-24	Pharmaceutical Delivery Systems	Bioerodible polymers for solid controlled release pharmaceutical compositions
DE4214215A1 (de) *	1992-04-30	1993-11-04	Behringwerke Ag	Verwendung von inhibitoren von plasminogenaktivatoren zur behandlung von entzuendungen
WO1993023075A1 (en) *	1992-05-14	1993-11-25	Oncologix, Inc.	Treatment of vascular leakage syndrome and collagenase induced disease by administration of matrix metalloproteinase inhibitors
WO1993023555A1 (en)	1992-05-21	1993-11-25	The Penn State Research Foundation	Cultured taxus tissues as a source of taxol, related taxanes and other novel anti-tumor/anti-viral compounds
AU4406793A (en)	1992-06-04	1993-12-30	Clover Consolidated, Limited	Water-soluble polymeric carriers for drug delivery
US5383928A (en) *	1992-06-10	1995-01-24	Emory University	Stent sheath for local drug delivery
GB9213077D0 (en)	1992-06-19	1992-08-05	Erba Carlo Spa	Polymerbound taxol derivatives
US5274137A (en)	1992-06-23	1993-12-28	Nicolaou K C	Intermediates for preparation of taxols
US5294637A (en)	1992-07-01	1994-03-15	Bristol-Myers Squibb Company	Fluoro taxols
US5273965A (en)	1992-07-02	1993-12-28	Cambridge Biotech Corporation	Methods for enhancing drug delivery with modified saponins
FR2693193B1 (fr) *	1992-07-03	1994-09-02	Rhone Poulenc Rorer Sa	Nouveaux dérivés de la désacétyl-10 baccatine III, leur préparation et les compositions pharmaceutiques qui les contiennent.
US5472954A (en)	1992-07-14	1995-12-05	Cyclops H.F.	Cyclodextrin complexation
KR940003548U (ko)	1992-08-14	1994-02-21	김형술	세탁물 건조기
US5202448A (en)	1992-08-14	1993-04-13	Napro Biotherapeutics, Inc.	Processes of converting taxanes into baccatin III
WO1994005282A1 (en)	1992-09-04	1994-03-17	The Scripps Research Institute	Water soluble taxol derivatives
US5342621A (en) *	1992-09-15	1994-08-30	Advanced Cardiovascular Systems, Inc.	Antithrombogenic surface
DK0752885T3 (da)	1992-09-25	2003-11-03	Neorx Corp	Terapeutisk inhibitor for celler i den glatte karmuskulatur
US5770609A (en)	1993-01-28	1998-06-23	Neorx Corporation	Prevention and treatment of cardiovascular pathologies
US6306421B1 (en) *	1992-09-25	2001-10-23	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
CA2100808A1 (en)	1992-10-01	1994-04-02	Vittorio Farina	Deoxy paclitaxels
FR2696461B1 (fr)	1992-10-05	1994-11-10	Rhone Poulenc Rorer Sa	Nouveaux dérivés d'analogues du taxol, leur préparation et les compositions qui les contiennent.
FR2696462B1 (fr)	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé d'obtention de la désacétyl-10 baccatine III.
FR2696464B1 (fr)	1992-10-05	1994-11-10	Rhone Poulenc Rorer Sa	Nouveau procédé d'estérification de la baccatine III et de la désacétyl-10 baccatine III.
FR2696463B1 (fr)	1992-10-05	1994-11-25	Rhone Poulenc Rorer Sa	Procédé d'obtention de la désacétyl-10 baccatine III.
FR2698543B1 (fr)	1992-12-02	1994-12-30	Rhone Poulenc Rorer Sa	Nouvelles compositions à base de taxoides.
US5342348A (en) *	1992-12-04	1994-08-30	Kaplan Aaron V	Method and device for treating and enlarging body lumens
US5380751A (en)	1992-12-04	1995-01-10	Bristol-Myers Squibb Company	6,7-modified paclitaxels
US5279949A (en)	1992-12-07	1994-01-18	Board Of Trustees Operating Michigan State University	Process for the isolation and purification of taxol and taxanes from Taxus spp
EP0604022A1 (en)	1992-12-22	1994-06-29	Advanced Cardiovascular Systems, Inc.	Multilayered biodegradable stent and method for its manufacture
US5419760A (en) *	1993-01-08	1995-05-30	Pdt Systems, Inc.	Medicament dispensing stent for prevention of restenosis of a blood vessel
US6663881B2 (en)	1993-01-28	2003-12-16	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5981568A (en) *	1993-01-28	1999-11-09	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US6491938B2 (en)	1993-05-13	2002-12-10	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
US5439686A (en)	1993-02-22	1995-08-08	Vivorx Pharmaceuticals, Inc.	Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US5378456A (en) *	1993-03-25	1995-01-03	American Cyanamid Company	Antitumor mitoxantrone polymeric compositions
WO1994024961A1 (en)	1993-04-23	1994-11-10	Schneider (Usa) Inc.	Covered stent and stent delivery device
US5464650A (en)	1993-04-26	1995-11-07	Medtronic, Inc.	Intravascular stent and method
WO1994026291A1 (en) *	1993-05-13	1994-11-24	Neorx Corporation	Therapeutic inhibitor of vascular smooth muscle cells
IT1276342B1 (it)	1993-06-04	1997-10-30	Ist Naz Stud Cura Dei Tumori	Stent metallico rivestito con materiale polimerico biocompatibile
US5468769A (en)	1993-07-15	1995-11-21	Abbott Laboratories	Paclitaxel derivatives
US5886026A (en) *	1993-07-19	1999-03-23	Angiotech Pharmaceuticals Inc.	Anti-angiogenic compositions and methods of use
US20030203976A1 (en) *	1993-07-19	2003-10-30	William L. Hunter	Anti-angiogenic compositions and methods of use
KR100389223B1 (ko) *	1993-07-19	2003-10-08	안지오제네시스 테크놀로지스, 인코포레이티드	생체내통로관강을개방유지하기위한스텐트및이의제조방법
AU771815B2 (en)	1993-07-19	2004-04-01	Angiotech Pharmaceuticals, Inc.	Anti-angiogenic compositions and methods of use
AU728873B2 (en)	1993-07-19	2001-01-18	Angiotech Pharmaceuticals, Inc.	Anti-angiogenic compositions and methods of use
ATE255412T1 (de)	1993-07-29	2003-12-15	Us Gov Health & Human Serv	Verfahren zur behandlung atherosklerose oder restenose mit hilfe eines mikrotubulusstabilisators
US5380299A (en) *	1993-08-30	1995-01-10	Med Institute, Inc.	Thrombolytic treated intravascular medical device
US5455046A (en)	1993-09-09	1995-10-03	Edward Mendell Co., Inc.	Sustained release heterodisperse hydrogel systems for insoluble drugs
US5457113A (en) *	1993-10-15	1995-10-10	Eli Lilly And Company	Methods for inhibiting vascular smooth muscle cell proliferation and restinosis
US5643575A (en)	1993-10-27	1997-07-01	Enzon, Inc.	Non-antigenic branched polymer conjugates
US5415869A (en)	1993-11-12	1995-05-16	The Research Foundation Of State University Of New York	Taxol formulation
US5443505A (en)	1993-11-15	1995-08-22	Oculex Pharmaceuticals, Inc.	Biocompatible ocular implants
CA2176934A1 (en) *	1993-11-17	1995-05-26	Ramnath Sasisekharan	Method for inhibiting angiogenesis using heparinase
US5462726A (en)	1993-12-17	1995-10-31	Bristol-Myers Squibb Company	Method of inhibiting side effects of solvents containing ricinoleic acid or castor oil or derivatives thereof employing a thromboxane A2 receptor antagonist and pharmaceutical compositions containing such solvents
CA2147813A1 (en)	1994-04-28	1995-10-29	Richard Dixon	Intravascular prosthesis with anti-thrombogenic coating
US5626862A (en)	1994-08-02	1997-05-06	Massachusetts Institute Of Technology	Controlled local delivery of chemotherapeutic agents for treating solid tumors
US5489589A (en)	1994-12-07	1996-02-06	Bristol-Myers Squibb Company	Amino acid derivatives of paclitaxel
US6231600B1 (en)	1995-02-22	2001-05-15	Scimed Life Systems, Inc.	Stents with hybrid coating for medical devices
JP3224121B2 (ja)	1995-04-24	2001-10-29	ヤマハ発動機株式会社	自動二輪車用ステアリングヘッド部材
US5801191A (en)	1995-06-01	1998-09-01	Biophysica Foundation	Taxoids
US5766584A (en)	1995-06-02	1998-06-16	Massachusetts Institute Of Technology	Inhibition of vascular smooth muscle cell proliferation with implanted matrix containing vascular endothelial cells
US6783543B2 (en) *	2000-06-05	2004-08-31	Scimed Life Systems, Inc.	Intravascular stent with increasing coating retaining capacity
WO1997045105A1 (en) *	1996-05-24	1997-12-04	Angiotech Pharmaceuticals, Inc.	Compositions and methods for treating or preventing diseases of body passageways
CA2288198A1 (en)	1997-03-25	1998-10-01	Daniel I. Simon	Modulation of vascular healing by inhibition of leukocyte adhesion and function
ES2388248T3 (es)	1997-03-31	2012-10-11	Boston Scientific Scimed Limited	Forma de dosificación que comprende taxol en forma cristalina
US6273908B1 (en) *	1997-10-24	2001-08-14	Robert Ndondo-Lay	Stents
CA2291066A1 (en)	1998-03-23	1999-09-30	Conjuchem, Inc.	Local delivery of long lasting therapeutic agents
US6241762B1 (en)	1998-03-30	2001-06-05	Conor Medsystems, Inc.	Expandable medical device with ductile hinges
US7208010B2 (en)	2000-10-16	2007-04-24	Conor Medsystems, Inc.	Expandable medical device for delivery of beneficial agent
EP1132058A1 (en)	2000-03-06	2001-09-12	Advanced Laser Applications Holding S.A.	Intravascular prothesis
US6395326B1 (en) *	2000-05-31	2002-05-28	Advanced Cardiovascular Systems, Inc.	Apparatus and method for depositing a coating onto a surface of a prosthesis
AU2002235175A1 (en)	2000-12-06	2002-06-18	Tularik, Inc.	Lometrexol combination therapy
JP3502053B2 (ja)	2001-03-15	2004-03-02	パナソニックコミュニケーションズ株式会社	複合機
CN100436678C (zh) *	2002-06-20	2008-11-26	费德罗-莫格尔动力系公司	多层隔离套筒
JP3990961B2 (ja) *	2002-09-09	2007-10-17	株式会社コナミデジタルエンタテインメント	ゲーム機およびビンゴゲーム機
US20040127976A1 (en) *	2002-09-20	2004-07-01	Conor Medsystems, Inc.	Method and apparatus for loading a beneficial agent into an expandable medical device
US20070003636A1 (en) *	2003-01-22	2007-01-04	Francois Mach	Statins (HMG-COA reductase inhibitors) as a novel type of immunomodulator, immunosuppressor and anti-inflammatory agent
US20050100577A1 (en)	2003-11-10	2005-05-12	Parker Theodore L.	Expandable medical device with beneficial agent matrix formed by a multi solvent system

1994
- 1994-07-19 KR KR1019960700266A patent/KR100389223B1/ko not_active Expired - Lifetime
- 1994-07-19 PT PT01117863T patent/PT1155689E/pt unknown
- 1994-07-19 DE DE69435002T patent/DE69435002T2/de not_active Expired - Lifetime
- 1994-07-19 RU RU96105391/14A patent/RU2180844C2/ru active
- 1994-07-19 ES ES01117873T patent/ES2290074T3/es not_active Expired - Lifetime
- 1994-07-19 DK DK01117863T patent/DK1155689T3/da active
- 1994-07-19 NZ NZ511762A patent/NZ511762A/en not_active IP Right Cessation
- 1994-07-19 CN CNB941933792A patent/CN1138505C/zh not_active Expired - Lifetime
- 1994-07-19 CA CA002468375A patent/CA2468375A1/en not_active Abandoned
- 1994-07-19 DE DE69434856T patent/DE69434856T4/de not_active Expired - Lifetime
- 1994-07-19 DK DK96119361T patent/DK0797988T3/da active
- 1994-07-19 DK DK10153077.2T patent/DK2226085T3/da active
- 1994-07-19 DK DK01117873T patent/DK1159974T3/da active
- 1994-07-19 EP EP01117882A patent/EP1159975B1/en not_active Revoked
- 1994-07-19 CA CA002167268A patent/CA2167268C/en not_active Expired - Lifetime
- 1994-07-19 JP JP50482395A patent/JP3423317B2/ja not_active Expired - Fee Related
- 1994-07-19 CN CNA2006100998899A patent/CN100998869A/zh active Pending
- 1994-07-19 DE DE69435185T patent/DE69435185D1/de not_active Expired - Lifetime
- 1994-07-19 ES ES94920360T patent/ES2106553T5/es not_active Expired - Lifetime
- 1994-07-19 AT AT01117872T patent/ATE277649T1/de not_active IP Right Cessation
- 1994-07-19 EP EP10153077.2A patent/EP2226085B1/en not_active Expired - Lifetime
- 1994-07-19 CN CN2006100998884A patent/CN101185759B/zh not_active Expired - Lifetime
- 1994-07-19 AT AT05020782T patent/ATE502664T1/de not_active IP Right Cessation
- 1994-07-19 DE DE69435341T patent/DE69435341D1/de not_active Expired - Lifetime
- 1994-07-19 KR KR1020097015869A patent/KR20090090403A/ko not_active Ceased
- 1994-07-19 AT AT05020791T patent/ATE537858T1/de active
- 1994-07-19 EP EP05020783A patent/EP1695697A3/en not_active Withdrawn
- 1994-07-19 AT AT01117876T patent/ATE408429T1/de not_active IP Right Cessation
- 1994-07-19 KR KR1020117007294A patent/KR101222904B1/ko not_active Expired - Lifetime
- 1994-07-19 EP EP01117872A patent/EP1155690B1/en not_active Expired - Lifetime
- 1994-07-19 NZ NZ533467A patent/NZ533467A/en not_active IP Right Cessation
- 1994-07-19 EP EP05020782A patent/EP1652539B8/en not_active Expired - Lifetime
- 1994-07-19 CA CA002472373A patent/CA2472373C/en not_active Expired - Lifetime
- 1994-07-19 AT AT01117863T patent/ATE339975T1/de active
- 1994-07-19 PT PT01117873T patent/PT1159974E/pt unknown
- 1994-07-19 AT AT05020792T patent/ATE502625T1/de not_active IP Right Cessation
- 1994-07-19 KR KR1020087007363A patent/KR20080043375A/ko not_active Ceased
- 1994-07-19 AU AU71192/94A patent/AU693797B2/en not_active Expired
- 1994-07-19 ES ES01117863T patent/ES2267638T3/es not_active Expired - Lifetime
- 1994-07-19 EP EP05020792A patent/EP1695698B1/en not_active Expired - Lifetime
- 1994-07-19 EP EP08006468A patent/EP1946749A1/en not_active Withdrawn
- 1994-07-19 DE DE69434048T patent/DE69434048T2/de not_active Expired - Lifetime
- 1994-07-19 EP EP01117863A patent/EP1155689B1/en not_active Revoked
- 1994-07-19 AT AT94920360T patent/ATE154757T1/de active
- 1994-07-19 CN CNA2003101198825A patent/CN1502331A/zh active Pending
- 1994-07-19 DE DE69435141T patent/DE69435141D1/de not_active Expired - Lifetime
- 1994-07-19 EP EP05020791A patent/EP1632259B1/en not_active Expired - Lifetime
- 1994-07-19 CN CNA200610099887XA patent/CN100998565A/zh active Pending
- 1994-07-19 AT AT01117873T patent/ATE367173T1/de not_active IP Right Cessation
- 1994-07-19 EP EP96119361A patent/EP0797988B1/en not_active Expired - Lifetime
- 1994-07-19 DE DE69434856A patent/DE69434856D1/de not_active Expired - Lifetime
- 1994-07-19 EP EP01117876A patent/EP1155691B1/en not_active Expired - Lifetime
- 1994-07-19 NZ NZ268326A patent/NZ268326A/en not_active IP Right Cessation
- 1994-07-19 AT AT01117882T patent/ATE407712T1/de not_active IP Right Cessation
- 1994-07-19 ES ES10153077.2T patent/ES2449311T3/es not_active Expired - Lifetime
- 1994-07-19 DE DE69435342T patent/DE69435342D1/de not_active Expired - Lifetime
- 1994-07-19 EP EP01117873A patent/EP1159974B1/en not_active Revoked
- 1994-07-19 CN CN2005100822079A patent/CN1704121B/zh not_active Expired - Lifetime
- 1994-07-19 PT PT101530772T patent/PT2226085E/pt unknown
- 1994-07-19 PT PT96119361T patent/PT797988E/pt unknown
- 1994-07-19 NZ NZ523799A patent/NZ523799A/en not_active IP Right Cessation
- 1994-07-19 CN CNA2006100998901A patent/CN101007173A/zh active Pending
- 1994-07-19 DK DK94920360T patent/DK0706376T4/da active
- 1994-07-19 DE DE69435139T patent/DE69435139D1/de not_active Expired - Lifetime
- 1994-07-19 CA CA002472404A patent/CA2472404A1/en not_active Abandoned
- 1994-07-19 DE DE69403966T patent/DE69403966T3/de not_active Expired - Lifetime
- 1994-07-19 WO PCT/CA1994/000373 patent/WO1995003036A1/en active Application Filing
- 1994-07-19 AT AT96119361T patent/ATE420628T1/de active
- 1994-07-19 EP EP94920360A patent/EP0706376B2/en not_active Expired - Lifetime
- 1994-07-19 ES ES96119361T patent/ES2321241T3/es not_active Expired - Lifetime
1996
- 1996-01-18 NO NO19960226A patent/NO324275B1/no not_active IP Right Cessation
1997
- 1997-09-24 GR GR970402471T patent/GR3024833T3/el unknown
- 1997-11-17 NZ NZ329193A patent/NZ329193A/xx not_active IP Right Cessation
1999
- 1999-04-19 US US09/294,458 patent/US6506411B2/en not_active Expired - Fee Related
2001
- 2001-08-08 US US09/925,220 patent/US6544544B2/en not_active Expired - Fee Related
- 2001-08-09 US US09/927,882 patent/US20020119202A1/en not_active Abandoned
- 2001-11-28 RU RU2001132111/15A patent/RU2304433C2/ru not_active Application Discontinuation
2002
- 2002-03-11 JP JP2002066179A patent/JP4476536B2/ja not_active Expired - Lifetime
- 2002-05-29 HK HK02103990.2A patent/HK1042054B/en not_active IP Right Cessation
- 2002-11-29 KR KR1020027016338A patent/KR100934111B1/ko not_active Expired - Lifetime
2003
- 2003-03-13 US US10/389,262 patent/US20040076672A1/en not_active Abandoned
- 2003-03-14 US US10/390,534 patent/US20040062810A1/en not_active Abandoned
2004
- 2004-10-07 US US10/959,349 patent/US7820193B2/en not_active Expired - Fee Related
- 2004-10-07 US US10/959,398 patent/US20050208137A1/en not_active Abandoned
2005
- 2005-06-14 US US11/151,399 patent/US20060127445A1/en not_active Abandoned
2006
- 2006-01-17 US US11/332,170 patent/US20060121117A1/en not_active Abandoned
- 2006-05-18 US US11/435,780 patent/US20070003629A1/en not_active Abandoned
- 2006-05-18 US US11/435,854 patent/US20070003630A1/en not_active Abandoned
- 2006-05-18 US US11/435,742 patent/US20060240113A1/en not_active Abandoned
- 2006-09-04 JP JP2006239650A patent/JP4920353B2/ja not_active Expired - Lifetime
- 2006-12-07 JP JP2006331088A patent/JP4597115B2/ja not_active Expired - Lifetime
2007
- 2007-03-29 RU RU2007111679/15A patent/RU2007111679A/ru unknown
- 2007-06-15 NO NO20073066A patent/NO20073066L/no not_active Application Discontinuation
- 2007-07-30 US US11/830,240 patent/US20080166387A1/en not_active Abandoned
- 2007-07-30 US US11/830,208 patent/US20090074830A1/en not_active Abandoned
- 2007-07-30 US US11/830,186 patent/US20080020063A1/en not_active Abandoned
- 2007-07-30 US US11/830,080 patent/US20070298123A1/en not_active Abandoned
2008
- 2008-04-04 US US12/098,173 patent/US20090036517A1/en not_active Abandoned
2010
- 2010-03-03 US US12/716,854 patent/US8221794B2/en not_active Expired - Fee Related
- 2010-06-17 US US12/817,682 patent/US20110071612A1/en not_active Abandoned
- 2010-06-22 US US12/820,572 patent/US20100292314A1/en not_active Abandoned
- 2010-06-22 US US12/820,523 patent/US20110066251A1/en not_active Abandoned
- 2010-06-22 US US12/820,614 patent/US20110118825A1/en not_active Abandoned
2012
- 2012-07-13 US US13/549,282 patent/US20130102657A1/en not_active Abandoned
2014
- 2014-04-03 LU LU92423C patent/LU92423I2/xx unknown
- 2014-04-03 LU LU92422C patent/LU92422I2/xx unknown

Also Published As

Publication number	Publication date
EP1155689A2 (en)	2001-11-21
EP1652539A1 (en)	2006-05-03
NO324275B1 (no)	2007-09-17
US8221794B2 (en)	2012-07-17
DE69403966T2 (de)	1998-02-05
ATE408429T1 (de)	2008-10-15
CN100998565A (zh)	2007-07-18
US20090074830A1 (en)	2009-03-19
PT2226085E (pt)	2014-03-04
KR20090090403A (ko)	2009-08-25
EP1155691A3 (en)	2002-05-29
HK1079715A1 (zh)	2006-04-13
DK1155689T3 (da)	2006-11-20
US20070003630A1 (en)	2007-01-04
NZ533467A (en)	2006-02-24
JP3423317B2 (ja)	2003-07-07
US20040062810A1 (en)	2004-04-01
LU92423I2 (en)	2015-01-20
DK0706376T5 (da)	2006-05-15
DK2226085T3 (da)	2014-02-03
JP4476536B2 (ja)	2010-06-09
EP0797988A2 (en)	1997-10-01
ATE502664T1 (de)	2011-04-15
KR101222904B1 (ko)	2013-01-17
ATE154757T1 (de)	1997-07-15
AU693797B2 (en)	1998-07-09
RU2007111679A (ru)	2008-10-10
DE69435185D1 (de)	2009-03-05
DE69435341D1 (de)	2011-05-05
EP1159975A3 (en)	2002-03-27
EP2226085B1 (en)	2013-11-27
DE69434856D1 (de)	2006-11-02
DE69403966T3 (de)	2008-04-17
DE69434856T2 (de)	2007-03-01
US20060240113A1 (en)	2006-10-26
US20040076672A1 (en)	2004-04-22
DK0706376T4 (da)	2007-12-10
CA2468375A1 (en)	1995-02-02
US20110071612A1 (en)	2011-03-24
CA2472373C (en)	2009-10-13
EP1155691A2 (en)	2001-11-21
US6506411B2 (en)	2003-01-14
PT797988E (pt)	2009-05-19
EP0706376B2 (en)	2007-08-08
CN101185759B (zh)	2011-05-25
US6544544B2 (en)	2003-04-08
EP1155690A2 (en)	2001-11-21
EP1695697A3 (en)	2007-12-26
DE69434048T2 (de)	2005-10-06
KR100389223B1 (ko)	2003-10-08
US20070003629A1 (en)	2007-01-04
PT1155689E (pt)	2007-01-31
GR3024833T3 (en)	1998-01-30
DE69435002D1 (de)	2007-08-30
EP1652539B8 (en)	2011-06-15
ATE407712T1 (de)	2008-09-15
KR20080043375A (ko)	2008-05-16
CN1138505C (zh)	2004-02-18
CN1704121B (zh)	2010-08-18
CN100998869A (zh)	2007-07-18
ES2290074T3 (es)	2008-02-16
EP1159974B1 (en)	2007-07-18
DE69435342D1 (de)	2011-05-05
EP1695697A1 (en)	2006-08-30
US7820193B2 (en)	2010-10-26
ES2106553T3 (es)	1997-11-01
US20090036517A1 (en)	2009-02-05
ATE420628T1 (de)	2009-01-15
CN101007173A (zh)	2007-08-01
US20020119202A1 (en)	2002-08-29
CA2167268A1 (en)	1995-02-02
ATE339975T1 (de)	2006-10-15
JPH09503488A (ja)	1997-04-08
RU2304433C2 (ru)	2007-08-20
KR20030097620A (ko)	2003-12-31
AU7119294A (en)	1995-02-20
DK1159974T3 (da)	2007-11-26
US20130102657A1 (en)	2013-04-25
ATE537858T1 (de)	2012-01-15
ATE367173T1 (de)	2007-08-15
EP1632259B1 (en)	2011-12-21
NO20073066L (no)	1996-03-18
JP4597115B2 (ja)	2010-12-15
DK0706376T3 (da)	1997-10-13
EP1632259A3 (en)	2006-08-09
CN1130866A (zh)	1996-09-11
EP0706376B1 (en)	1997-06-25
US20100240742A1 (en)	2010-09-23
RU2180844C2 (ru)	2002-03-27
ES2449311T3 (es)	2014-03-19
EP0706376A1 (en)	1996-04-17
KR20110049898A (ko)	2011-05-12
ES2321241T3 (es)	2009-06-03
CA2167268C (en)	2004-09-28
ES2267638T3 (es)	2007-03-16
US20020164377A1 (en)	2002-11-07
ATE277649T1 (de)	2004-10-15
CN101185759A (zh)	2008-05-28
PT1159974E (pt)	2007-10-31
NZ268326A (en)	1997-12-19
EP1632259A2 (en)	2006-03-08
EP0797988B1 (en)	2009-01-14
EP1652539B1 (en)	2011-03-23
EP1695698A1 (en)	2006-08-30
RU2001132111A (ru)	2003-07-27
NO960226L (no)	1996-03-18
US20050123605A1 (en)	2005-06-09
EP1155690A3 (en)	2001-11-28
US20110118825A1 (en)	2011-05-19
EP2226085A1 (en)	2010-09-08
DE69403966D1 (de)	1997-07-31
DK0797988T3 (da)	2009-05-11
DE69434856T4 (de)	2009-09-24
ES2106553T5 (es)	2008-02-16
EP0797988A3 (en)	2000-11-22
EP1159974A1 (en)	2001-12-05
EP1159975A2 (en)	2001-12-05
US20060121117A1 (en)	2006-06-08
NZ523799A (en)	2005-03-24
EP1155689A3 (en)	2001-11-28
EP1155689B1 (en)	2006-09-20
US20100292314A1 (en)	2010-11-18
CA2472404A1 (en)	1995-02-02
US20060127445A1 (en)	2006-06-15
ATE502625T1 (de)	2011-04-15
JP4920353B2 (ja)	2012-04-18
DE69435139D1 (de)	2008-10-23
CA2472373A1 (en)	1995-02-02
US20080166387A1 (en)	2008-07-10
HK1042054B (en)	2008-11-14
JP2002326930A (ja)	2002-11-15
DE69435141D1 (de)	2008-10-30
JP2007084572A (ja)	2007-04-05
EP1946749A1 (en)	2008-07-23
NZ329193A (en)	2001-08-31
HK1042054A1 (en)	2002-08-02
EP1155691B1 (en)	2008-09-17
US20110066251A1 (en)	2011-03-17
WO1995003036A1 (en)	1995-02-02
CN1704121A (zh)	2005-12-07
CN1502331A (zh)	2004-06-09
US20030003094A1 (en)	2003-01-02
NZ511762A (en)	2003-09-26
US20080020063A1 (en)	2008-01-24
KR100934111B1 (ko)	2009-12-31
US20070298123A1 (en)	2007-12-27
DE69435002T2 (de)	2008-03-20
EP1695698B1 (en)	2011-03-23
NO960226D0 (no)	1996-01-18
DE69434048D1 (de)	2004-11-04
EP1155690B1 (en)	2004-09-29
US20050208137A1 (en)	2005-09-22
JP2006328086A (ja)	2006-12-07
EP1159975B1 (en)	2008-09-10

Publication	Publication Date	Title
LU92422I2 (en)	2015-01-20	Taxol
AU7628500A (en)	2001-03-05	Dilatation/centering catheter for the treatment of stenosis
IL142172A0 (en)	2002-03-10	Treatment of restenosis
MY140504A (en)	2009-12-31	Statin-mmp inhibitor combinations
ES2142515T3 (es)	2000-04-16	Procedimiento para la preparacion de (co)polimeros de alfa-olefinas.
AU7389496A (en)	1997-04-28	Methods and compositions for treating vascular stenosis